<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <div xmlns="" tagxxx="article">
      <head>
         <meta content="Hindawi Publishing Corporation" name="citation_publisher"></meta>
         <meta content="10.1155/2013/838491" name="citation_doi"></meta>
         <meta content="Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections" name="citation_title"></meta>
         <title>Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections</title>
         <div tagxxx="contrib-group">
            <meta content="Giuseppe Sautto" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
            <meta content="Nicasio Mancini" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
            <meta content="Giacomo Gorini" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
            <meta content="Massimo Clementi" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
            <meta content="Roberto Burioni" name="citation_author"></meta>
            <meta content="" name="citation_author_institution_ref"></meta>
         </div>
         <meta content="sautto.giuseppe@hsr.it" name="email"></meta>
         <meta content="" name="conflict"></meta>
         <meta content="" name="contribs"></meta>
         <meta content="2013-8-22" name="citation_pubdate"></meta>
         <meta content="Copyright 2013: " name="citation_copyright"></meta>
         <meta content="Licence This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited." name="citation_licence"></meta>
         <meta content="" name="citation_funding"></meta>
         <meta content="" name="citation_pagecount"></meta>
         <meta content="" name="citation_data"></meta>
      </head>
      <div id="abstract" tag="abstract">
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">More than 150 arboviruses belonging to different families are known to infect humans,
            causing endemic infections as well as epidemic outbreaks. Effective vaccines to limit
            the occurrence of some of these infections have been licensed, while for the others
            several new immunogens are under development mostly for their improvements concerning
            safety and effectiveness profiles. On the other hand, specific and effective antiviral
            drugs are not yet available, posing an urgent medical need in particular for emergency
            cases. Neutralizing monoclonal antibodies (mAbs) have been demonstrated to be effective
            in the treatment of several infectious diseases as well as in preliminary 
            <i>in vitro</i> and 
            <i>in vivo</i> models of arbovirus-related infections. Given their specific antiviral activity as
            well-tolerated molecules with limited side effects, mAbs could represent a new therapeutic
            approach for the development of an effective treatment, as well as useful tools in
            the study of the host-virus interplay and in the development of more effective immunogens.
            However, before their use as candidate therapeutics, possible hurdles (e.g., Ab-dependent
            enhancement of infection, occurrence of viral escape variants) must be carefully evaluated.
            In this review are described the main arboviruses infecting humans and candidate mAbs
            to be possibly used in a future passive immunotherapy.
         </p>
      </div>
      <div id="sec1">
         <h2>1. Introduction</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arthropod-borne virus (arbovirus) infections are increasingly becoming an emerging
            medical problem mostly affecting endemic areas such as developing countries or upcoming
            economies (like China and India). In particular, the major outbreak source of arbovirus-related
            diseases in endemic areas is mostly related to the presence of the viruses in an animal
            reservoir and a following expansion in humans. Moreover, epidemic episodes, which
            occur mainly during seasons with increased disease activity or outbreaks (e.g., because
            of climate variations), have also been described. In addition, increasing traveling
            to exotic and medically high-risk locations has enlarged this problem also to previously
            non-endemic areas, due to the global rise of travelers and movement of large populations
            [
            <span ref-type="bibr" rid="B1">1</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Of the over 545 suspected arbovirus species, the most known virus-transmitting arthropods
            (vectors) are mosquitoes (mostly female 
            <i>Aedes aegypti</i> and 
            <i>Aedes albopictus</i>), ticks, midges, and sandflies. Humans are usually dead-end hosts, as they do not
            develop the high viremia required to infect arthropods that is sustained by vertebrate
            animal reservoirs [
            <span ref-type="bibr" rid="B1">1</span>]. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Although several arboviruses of clinical significance in humans are known (more than
            150), only a restricted group of them is globally diffused, the majority of which
            are zoonotic and belong to the Flaviviridae, Bunyaviridae, or Togaviridae families,
            with a small number belonging to Reoviridae and Orthomyxoviridae [
            <span ref-type="bibr" rid="B1">1</span>]. Highly effective vaccines for several of them are available, including tick-borne
            encephalitis (TBEV) [
            <span ref-type="bibr" rid="B2">2</span>], yellow fever (YFV) [
            <span ref-type="bibr" rid="B3">3</span>], and Japanese encephalitis (JEV) viruses [
            <span ref-type="bibr" rid="B4">4</span>], but for no one of them a specific antiviral drug is currently approved for clinical
            use. In the course of viral infections, neutralizing monoclonal antibody (mAb)-based
            therapy represents a promising and safe alternative strategy, in particular when a
            specific and efficacious treatment is not yet available [
            <span ref-type="bibr" rid="B5">5</span>–
            <span ref-type="bibr" rid="B11">11</span>]. At present, human mAb-based passive immunotherapies for arbovirosis are at very
            early stage of development. However, previous studies in mice have shown that passive
            transfer of either monoclonal or polyclonal Abs can be protective against homologous
            or heterologous dengue virus (DENV) challenge as well as against other 
            <i>flaviviruses</i> and human arboviruses. Moreover, engineering rendering mAbs capable of crossing the
            blood-brain barrier in order to limit viral dissemination within CNS may be considered.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Finally, a possible administration of mAbs in those subjects that could be at risk
            of exposure to arbovirus infections, such as travelers in endemic areas, could reduce
            the possible incidence and consequent augmented risk of epidemic episodes. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In this review, we describe the major clinical relevant and worldwide diffused arboviruses
            infecting humans and the recently major described mAbs to be possibly used in a future
            passive immunotherapy. 
         </p>
      </div>
      <div id="sec2">
         <h2>2. 
            <i>Flaviviruses </i>
         </h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The 
            <i>Flavivirus</i> genus, including more than 70 viruses, is the only one within the Flaviviridae family
            which holds arboviruses that are responsible for significant morbidity and mortality
            worldwide [
            <span ref-type="bibr" rid="B12">12</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">About 2.5 billion people are at risk of infection in tropical and subtropical countries,
            mainly South-East and South Asia, Central and South America, and the Caribbean. In
            addition, multiple 
            <i>Flavivirus</i> infections have been reported in the same areas, complicating early diagnosis and
            identification [
            <span ref-type="bibr" rid="B13">13</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <i>Flavivirus</i> infections can cause fever, encephalitis, hemorrhagic disease, flaccid paralysis,
            and death in humans. However, the immunopathogenesis of these viruses is not fully
            understood. In the last decade, the 
            <i>flaviviruses</i> have reemerged as aggressive human pathogens [
            <span ref-type="bibr" rid="B13">13</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The human 
            <i>flaviviruses</i> includes 53 recognized species. However, five of them are considered clinically important
            like DENV, YFV, JEV, TBEV, and West Nile virus (WNV).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The genome of all the members of the Flaviviridae family consists of a 9.5–12.5 kb
            positive-sense, single-stranded RNA. They are enveloped small virions (40–60 nm in
            diameter) with two or more species of envelope glycoproteins (e.g., M and E proteins),
            which are involved in the binding and fusion processes. In particular, the precursor
            of the mature M protein (prM) interacts with E glycoproteins, acting as a chaperone
            and preventing the fusion of the virus with the membrane in the cell during egress
            through acidic compartments of the secretory pathway. Then, cleavage of prM by the
            cellular protease furin during transit through the Golgi network is a required step
            in the viral lifecycle that defines the transition from an immature non-infectious
            virus particle into an infectious form. However, immature infectious virions retaining
            some uncleaved prM molecules could be released [
            <span ref-type="bibr" rid="B14">14</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The M and E glycoproteins constitute an icosahedral scaffold surrounding a nucleocapsid,
            which consists of the viral genome complexed with a core of approximately 30 nm composed
            of multiple copies of a small, basic capsid (C) protein. Binding, uptake and fusion
            by target cells are believed to involve clathrin-mediated and low-pH-induced endocytosis
            [
            <span ref-type="bibr" rid="B14">14</span>]. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <i>Flaviviruses</i> can utilize multiple receptors for different cell types and host species. They are
            thought to firstly interact with dendritic cells through DC-SIGN and L-SIGN binding
            of glycans on E glycoprotein dimers. In addition, highly sulfated glycosaminoglycans
            (e.g., heparan sulfate) have been demonstrated to play an important role in the initial
            attachment of several 
            <i>flaviviruses</i> to their target cells. Other molecules identified as possible receptors are integrins,
            mannose-binding receptor on macrophages, laminin-binding protein, GRP78 (BiP), and
            CD14 [
            <span ref-type="bibr" rid="B15">15</span>]. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Uncoating and replication of the viral genome, through a minus-strand RNA intermediate,
            occurs in the cytoplasmic replication complexes associated with perinuclear membranes,
            where viral proteins are produced as part of a single long polyprotein of more than
            3,000 amino acids, generating three structural (C, prM, and E) and seven non-structural
            (NS1, NS2A, NS2B, the viral protease NS3, NS4A, NS4B, and the RNA-dependent RNA polymerase
            NS5) proteins by cleavage of host and viral proteases, respectively. Progeny virions
            are thought to assemble by budding into an intracellular membrane compartment, probably
            the endoplasmic reticulum, then transited through the host secretory pathway, and
            released at the cell surface [
            <span ref-type="bibr" rid="B16">16</span>]. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Efforts to develop effective prophylactic approaches for several clinically important
            
            <i>flaviviruses</i> are underway [
            <span ref-type="bibr" rid="B17">17</span>]. The crucial role of the humoral immune response against 
            <i>Flavivirus</i> infections is well established, as infection with one serotype provides life-long
            protective immunity to the homologous infecting serotype and cross-protection in the
            first few months against the other serotypes. Conversely, individuals experiencing
            a secondary infection with a distinct serotype are at greater risk of severe complications,
            as discussed later [
            <span ref-type="bibr" rid="B18">18</span>]. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Only a limited number of 
            <i>Flavivirus</i> vaccines are available today; however, no approved antiviral drugs are yet available
            for their clinical use. Thus, giving the lack of vaccines as well as specific antiviral
            drugs, broadly cross-neutralizing mAbs, could be helpful in the development of an
            effective therapeutic strategy against these infections as well as in the progress
            towards effective immunogens.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In the next paragraphs, we describe the molecular targets of 
            <i>flaviviruses</i>, including DENV, JEV, TBEV, WNV, YFV, and St. Louis encephalitis virus (SLEV) followed
            by a description of the therapeutic candidate mAbs directed against them. 
         </p>
         <div id="sec2.1">
            <h3>2.1. Domains and Functions of the Surface Envelope (E) Glycoprotein of 
               <i>Flaviviruses </i>
            </h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The major target of the host humoral immune response and of neutralizing Abs against
               
               <i>flaviviruses</i> is represented by the envelope (E) glycoprotein, which is a 56-kDa protein and the
               major represented antigen on the surface of virions [
               <span ref-type="bibr" rid="B19">19</span>]. However, Ab response towards other structural and non-structural proteins, such
               as prM and NS1, respectively, has also been described [
               <span ref-type="bibr" rid="B20">20</span>, 
               <span ref-type="bibr" rid="B21">21</span>]. However, prM-specific Abs display limited neutralizing activity, while anti-NS1
               Abs have been detected only during the convalescent period of a primary DENV infection
               but were strongly identified during the acute phase of a secondary DENV infection,
               suggesting that both Abs could contribute to the pathogenesis of the life-threatening
               dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) [
               <span ref-type="bibr" rid="B22">22</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The crystallographic structure of the E protein of TBEV has been proposed as a model
               for the envelope protein of the 
               <i>flaviviruses</i> [
               <span ref-type="bibr" rid="B23">23</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Further studies performed through X-ray crystallography have revealed that the E protein
               is a type II viral fusion protein with three 
               <i>β</i>-barrel domains (D): DI, DII, and DIII (corresponding to the antigenic domains C,
               A, and B, resp.) connected to the viral membrane by a helical structure called the
               stem anchor [
               <span ref-type="bibr" rid="B24">24</span>]. In its native form the E protein folds as an homodimer with an antiparallel structure
               and an unusual herringbone pseudoicosaedral symmetry pattern with the M protein located
               centrally within the symmetry, consistent with a head-to-tail configuration lying
               parallel to the envelope lipid bilayer. The DIII of the E glycoprotein (amino acid
               residues 295–395) has an immunoglobulin-like fold, contains seven 
               <i>β</i>-strands as well as type- and subcomplex-specific neutralizing B-cell epitopes and
               is the proposed receptor-binding domain through four peptide loops on the solvent
               exposed face. Directly linked to DIII, there is the stem/transmembrane region, spanning
               amino acid residues 401–495 and containing regions important for oligomerization with
               prM protein (amino acid residues 431–449 and 450–472) [
               <span ref-type="bibr" rid="B25">25</span>]. DII has a long, finger-like structure and contains two extended loops that project
               from DI and the highly conserved and hydrophobic glycine-rich fusion loop at its tip
               (amino acid residues 98–110), interacting with the stem region and the endosomal membrane
               of the cell during the fusion process [
               <span ref-type="bibr" rid="B26">26</span>]. In the trimeric conformation, the hydrophobic fusion peptide is exposed in DII
               to mediate the fusion with the membranes of the cell. DI is a ~120 amino acid central
               domain, formed by a discontinuous hinge region consisting in a central 
               <i>β</i>-barrel of eight strands that connects DII and DIII and plays a crucial role in the
               structural rearrangement of E from a homodimer to a trimer, which occurs on exposure
               to low pH of endosomes that is required for the membrane fusion process. In some 
               <i>flaviviruses</i>, an N-linked glycosylation site is present at amino acid position 154–156 of the
               E protein and does not appear to be necessary for E function, but it has been associated
               with the increased neuroinvasiveness of WNV lineage I outbreak strains from the USA
               and a pH-sensitive decrease in stability of the non-glycosylated strains [
               <span ref-type="bibr" rid="B27">27</span>].
            </p>
         </div>
         <div id="sec2.2">
            <h3>2.2. 
               <i>Flavivirus</i> Neutralizing B-Cell Epitopes
            </h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As previously described, Abs are a significant component of the host's protective
               response against 
               <i>Flavivirus</i> infections. However, virus-specific Abs have been implicated in the pathogenesis
               of severe clinical manifestations following a secondary DENV as well as YFV and WNV
               infections.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Moreover, cross-reactivity between 
               <i>Flavivirus</i> serogroups could complicate the interpretation of diagnostic assays but could be
               of interest in isolating cross-reactive and cross-neutralizing mAbs. However, Ab-dependent
               enhancement (ADE) of infection has been described for this genus as it represents
               the major risk of complications when reinfection occurs. Thus, great care must be
               taken in evaluating neutralizing activity and possible Ab-mediated infection enhancement
               in the characterization of future possible therapeutic mAbs against these viruses
               [
               <span ref-type="bibr" rid="B28">28</span>]. 
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">However, prophylactic and therapeutic use of neutralizing mAbs for 
               <i>Flavivirus</i> infections has been shown to be effective in animal models as reported later.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neutralizing epitopes were found to be located in each of the three domains of the
               E protein and have been confirmed to be surface exposed in the high-resolution X-ray
               crystal structure of the pre-fusion dimer of DENV2 E glycoprotein [
               <span ref-type="bibr" rid="B29">29</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Most potent mAbs against 
               <i>flaviviruses</i> are directed toward epitopes on DIII. For this reason, DIII-based immunogens are
               under evaluation as promising subunit 
               <i>Flavivirus</i> candidate vaccines [
               <span ref-type="bibr" rid="B30">30</span>, 
               <span ref-type="bibr" rid="B31">31</span>]. However, several cross-reactive mAbs that bind to residues from the AB loop were
               found to be poorly neutralizing as this loop projects toward the lipid bilayer in
               the mature viral particle. Conversely, lateral ridge region of DIII (e.g., BC, DE,
               and FG loops) is targeted by strong, serotype-specific neutralizing mAbs [
               <span ref-type="bibr" rid="B32">32</span>–
               <span ref-type="bibr" rid="B35">35</span>]. Cross-reactive mAbs specific for DII have also been described but with less neutralizing
               and variable profiles. However, few of them, whose epitope encompasses the fusion
               loop, are cross-reactive and neutralizing [
               <span ref-type="bibr" rid="B36">36</span>]. 
            </p>
         </div>
         <div id="sec2.3">
            <h3>2.3. Ab-Dependent Enhancement (ADE) of Infection</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
               <i>In vitro</i> and 
               <i>in vivo</i> studies have demonstrated that increased disease severity, causing DHF/DSS, upon
               reinfection with a different DENV serotype, is mostly due to the phenomenon of ADE
               of infection, determined by cross-reacting but poorly or non-neutralizing Abs, generated
               during the primary infection, that facilitate virus entry through Fc-
               <i>γ</i> or complement receptors present on cells, such as monocytes/macrophages (
               <span ref-type="fig" rid="fig1">Figure 1(a)</span>). Additionally, in 6 to 9 month-old children of DENV immune mothers, severe disease
               is associated with primary infection, possibly because of declining levels of neutralizing
               maternal Abs [
               <span ref-type="bibr" rid="B37">64</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">These cross-reactive Abs are mainly directed against the E and prM glycoproteins.
               In particular, experimental lines of evidence have suggested that cross-reactive Abs
               against DII of E protein can, under certain conditions, enhance infectivity of WNV
               
               <i>in vitro </i>[
               <span ref-type="bibr" rid="B38">65</span>]. However, the phenomenon of ADE could reflect the presence of non-neutralizing concentrations
               of virus-reactive Abs and has been observed for several 
               <i>flaviviruses in vitro </i>and 
               <i>in vivo</i>, such as WNV, TBEV, JEV, and YFV as well as other Flaviviridae members [
               <span ref-type="bibr" rid="B28">28</span>, 
               <span ref-type="bibr" rid="B39">66</span>–
               <span ref-type="bibr" rid="B41">68</span>]. In particular, it has been described that ADE of infection occurs at virus-bounded
               Ab concentrations in the upper limit by the stoichiometric threshold for neutralization,
               and at lower concentrations by the minimal number of Abs that allow attachment of
               the virion to cells. Furthermore, Abs that recognize infrequently displayed epitopes
               that do not support neutralization may enhance infection even at saturation [
               <span ref-type="bibr" rid="B42">69</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thus, the ADE of infection mechanism may pose a threat for the development of a safe
               and efficacious vaccine as well as a possible immunotherapy against Flaviviridae.
               
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Indeed, cross-neutralizing mAbs, as candidate therapeutics for these infections, may
               be considered after having well ascertained their broadly cross-neutralizing activity
               and the absence of possible mAb-mediated ADE of infection mechanisms. Alternatively,
               the risk of ADE of infection could be overtaken by the removal of the Ab heavy chain
               (i.e., the CH2 and CH3 portions or direct expression of the mAb as a Fab fragment)
               and/or deletion of the N-linked sugars on IgG molecules that are both required for
               interactions with Fc-
               <i>γ</i> receptors (Fc-
               <i>γ</i>R), or eventually, by the blocking of Fc-
               <i>γ</i>R engagement with anti-Fc-
               <i>γ</i>R Abs [
               <span ref-type="bibr" rid="B43">70</span>]. Similarly, the identification and detailed examination of cross-neutralizing epitopes
               that do not promote ADE of infection may define novel targets for vaccine development.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">However, in some instances, ADE of infection may occur when Ab molecules cross-react
               with both viral and cellular antigens (
               <span ref-type="fig" rid="fig1">Figure 1(c)</span>). In this regard, Fc-
               <i>γ</i> receptor-independent mechanism of infection, in particular for DENV prM-specific
               Abs able to bind simultaneously to the virus and target cells, has been described.
               Indeed, other members of the Flaviviridae belonging to another genus, like hepatitis
               C virus (HCV), have been shown to elicit polyreactive Abs that are probably responsible
               for an ADE of infection mechanism as well as of secondary clinical manifestations.
               In connection with this, several studies, employing both polyclonal and monoclonal
               Abs, suggested the presence of common epitopes containing particular short motifs
               on NS1 and the three domains of the E protein as well as human proteins that may play
               a role in ADE of infection mechanisms and thus in DHF/DSS pathogenesis [
               <span ref-type="bibr" rid="B43">70</span>]. Interestingly, these common motifs have been found to be additionally represented
               in DENV2 strains which have greater human pathogenic capacities [
               <span ref-type="bibr" rid="B22">22</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Moreover, another molecular mechanism of ADE of infection could consist in the facilitation
               of conformational changes of the targeted surface protein that are required for virus
               entry, as described and hypothesized for other viruses (e.g., HIV, HCV, and HSV) (
               <span ref-type="fig" rid="fig1">Figure 1(b)</span>) [
               <span ref-type="bibr" rid="B44">71</span>, 
               <span ref-type="bibr" rid="B45">72</span>]. 
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Finally, Fc-
               <i>γ</i>R engagement could result also in “intrinsic” ADE of infection mechanisms involving
               signaling events, such as inhibition of antiviral response and increased viral replication.
               Disrupted signaling events include the RIG-I/MDA5 cascade and type I interferon (IFN)
               response as well as induction and suppression of anti-inflammatory (IL-10) and proinflammatory
               (IL-12 and TNF-
               <i>α</i>) cytokines, respectively [
               <span ref-type="bibr" rid="B46">73</span>].
            </p>
         </div>
         <div id="sec2.4">
            <h3>2.4. Dengue Virus (DENV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dengue virus (DENV) is responsible for 50–100 million symptomatic infections each
               year, resulting in 500,000 hospitalizations and over 20,000 deaths which occurs mostly
               in tropical and subtropical regions of the world. Although malaria remains the most
               important cause for systemic febrile disease in travelers, chikungunya virus (CHIKV)
               and DENV are increasingly diagnosed, with dengue currently being the second most important
               cause for febrile disease in travelers.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Decreases in mosquito control efforts during the end of the 90s, coupled with societal
               factors (e.g., globalization, migrations, and dense urbanization) have contributed
               to the reemergence of 
               <i>flaviviruses</i> such as DENV in South and Central America. Development of effective DENV vaccines
               that exhibit cross-protection, thought to be important for preventing subsequent dengue-associated
               immunopathogenesis, is proving to be particularly challenging [
               <span ref-type="bibr" rid="B1">1</span>]. 
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A vaccine for this infection is not yet available despite considerable public and
               private efforts. This difficulty is mainly due to the perceived need to simultaneously
               protect the four known serotypes of DENV (DENV1–4), which share about 70% of sequence
               homology, while genotypes can vary up to 3%. Moreover, as anticipated and discussed
               previously, non-protective Abs may contribute to more severe clinical outcomes in
               vaccinated people [
               <span ref-type="bibr" rid="B47">74</span>].
            </p>
            <div id="sec2.4.1">
               <h3>2.4.1. Murine versus Human Anti-DENV Humoral Immune Response</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">It is well ascertained that anti-E DIII-directed Abs are virtually absent from the
                  naïve human repertoire as they are directed away from this domain, probably against
                  weakly neutralizing and immunodominant regions. Moreover, it has been demonstrated
                  that over than 90% of the human Ab response of primary DENV infected patients is able
                  to bind only native DENV virus particles instead of a recombinant form of the E protein,
                  posing difficulties in the cloning strategies of neutralizing mAbs [
                  <span ref-type="bibr" rid="B48">39</span>]. Thus, it can be concluded that 
                  <i>in vivo </i>only a small fraction of DENV-specific Abs are responsible for neutralization.
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conversely, murine mAbs that recognize all the three domains of E have been identified.
                  Epitope-mapping studies using murine serotype-specific mAbs have demonstrated that
                  loops located in the lateral ridge region of DIII constitute the strongest neutralizing
                  B-cell target. In this region, sequence diversity between serotype is high while cross-reactive
                  murine mAbs that recognize another loop showed generally a weaker neutralization profile.
                  In particular, type-specific mAbs with neutralizing activity against DENV2 localized
                  to the BC, DE, and FG loops on the lateral ridge of DIII, whereas subcomplex-specific
                  mAbs recognized an adjacent epitope centered on the connecting A strand of DIII at
                  residues K305, K307, and K310 [
                  <span ref-type="bibr" rid="B32">32</span>–
                  <span ref-type="bibr" rid="B35">35</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cross-reactive mAbs directed against prM and NS1 have also been described, but, as
                  anticipated, they feature weakly neutralizing or absent as well as ADE of infection
                  activity. In the following paragraphs, we report the better characterized neutralizing
                  mouse and human mAbs, describing their molecular features further summarized in 
                  <span ref-type="table" rid="tab1">Table 1</span>.
               </p>
            </div>
            <div id="sec2.4.2">
               <h3>2.4.2. Anti-DENV Murine mAbs</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Murine mAbs directed against all the three domains of the E protein and endowed of
                  different neutralizing and binding characteristics have been described. However, only
                  DIII and DII are classically recognized by neutralizing Abs. In this regard, Sukupolvi-Petty
                  et al. isolated twenty-four anti-DENV2 mouse mAbs with moderate or strong neutralizing
                  activity against the homologous virus in cell culture assays. Binding sites were mapped
                  for the majority of these in distinct epitopes in regions located in DI (lateral ridge),
                  DII (dimer interface, lateral ridge, and fusion loop), and DIII (lateral ridge, CC′
                  loop, and A strand). Moreover, 16 of the neutralizing mAbs were tested in mice, with
                  most of them being protective when given as prophylaxis. Seven of these had post-exposure
                  therapeutic activity when administered as a single dose by intraperitoneal route even
                  3 days after intracranial infection. For the mAbs with the greatest therapeutic potential,
                  protection was confirmed with an Ab-enhanced vascular leakage mouse model of DENV2
                  infection [
                  <span ref-type="bibr" rid="B35">35</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Recently, Deng et al. described a cross-reactive murine mAb, named 2A10G6, that is
                  able to recognize DENV1–4, YFV, WNV, JEV and TBEV, to potently cross-neutralize DENV1–4,
                  YFV and to a lesser extent WNV. This mAb recognizes a highly conserved motif (amino
                  acid residues 98–101) located within the fusion loop of the 
                  <i>Flavivirus</i> DII of the E glycoprotein. Moreover, this mAb exerts its neutralizing activity in
                  a post-attachment step during the virus entry process, as demonstrated by kinetic
                  neutralization tests performed 
                  <i>in vitro</i>. Additionally, protection experiments performed in mouse models showed that treatment
                  with 100 
                  <i>μ</i>g/mL of 2A10G6 conferred full protection against lethal DENV2 challenge, and 20 
                  <i>μ</i>g/mL and 4 
                  <i>μ</i>g/mL of 2A10G6 protected 89% and 40% of infected mice from lethal challenge, respectively.
                  For infection with DENV1, 3, and 4, use of 100 
                  <i>μ</i>g/mL of 2A10G6 conferred partial protection, and 53%, 77%, and 73% of the infected
                  mice survived after challenge, respectively. Finally, the protection profile of 2A10G6
                  against WNV showed that prophylactic administration with a single dose of 200 mg of
                  2A10G6 conferred 80% protection in mice. Most importantly, 3 of 8 (37.5%) mice survived
                  when 2A10G6 was administered one day after WNV challenge. Similarly, another mouse
                  mAb, 4G2, is able to recognize the fusion loop at the extremity of DII from all four
                  DENV serotypes and to prevent syncytia formation [
                  <span ref-type="bibr" rid="B36">36</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rajamanonmani et al. described a mouse mAb, 9F12, raised against the DIII of DENV2
                  E protein, that is able to recognize DENV1–4 serotypes as well as WNV and to neutralize
                  five DENV strains representative of all DENV serotypes [
                  <span ref-type="bibr" rid="B49">41</span>]. Similarly, Cockburn et al. reported a comparative, high-resolution crystallographic
                  analysis of an A-strand DIII murine mAb, 4E11, in complex with its target domain of
                  the E protein from the four DENV serotypes. MAb 4E11 is capable of recognizing and
                  neutralizing all four serotypes with IC50 values varying between 1 and 100 nM. The
                  structures reported also highlight the mechanism by which anti-A-strand mAbs disrupt
                  the architecture of the mature virion, inducing dimer dissociation, premature fusion-loop
                  exposure, and concomitant particle inactivation [
                  <span ref-type="bibr" rid="B50">40</span>]. Also, Midgley et al. functionally characterized another murine mAb, 2H12, raised
                  in mice against DIII of E protein. Similarly to the previously described mAbs; 2H12
                  is able to bind all the four DENV serotypes in a epitope encompassing the conserved
                  
                  <sup>314</sup>ETQH
                  <sup>317</sup> motif. However, the neutralizing potential of 2H12 is lower than a number of other
                  anti-DIII mAbs, with IC50 values ranging from 0.56 to 145 nM for DENV1, 2, and 4.
                  On the other hand, it showed no ADE of infection activity [
                  <span ref-type="bibr" rid="B51">38</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Austin et al. isolated a murine mAb, named E111, which recognize a novel CC′-loop
                  epitope on DIII of the E protein from two different DENV1 genotypes. Docking of the
                  mAb structure onto the available cryoelectron microscopy models of DENV virions revealed
                  that the E111 epitope was inaccessible, suggesting that this mAb recognizes an uncharacterized
                  virus conformation. While the affinity of binding between E111 and DIII varied by
                  genotype, a limited correlation with neutralizing activity was observed. These data
                  support the conclusion that potent neutralization depends on genotype-dependent exposure
                  of the CC′ loop epitope [
                  <span ref-type="bibr" rid="B52">49</span>]. In fact, as previously described elsewhere, binding of some E reactive Abs depends
                  on the dynamic movement of protein molecules “breathing” in the virion particle leading
                  to transient exposure of hidden epitopes. For instance, optimal binding of mouse mAb
                  1A1D-2 to EDIII requires incubation at 37°C [
                  <span ref-type="bibr" rid="B53">75</span>]. The structure of the 1A1D-2 bound to EDIII indicates that the mAb binds to sites
                  that are transiently exposed during viral “breathing” at 37°C and block infection
                  during attachment of the virion to the cell. In particular, this mAb neutralizes DENV1,
                  2, and 3 serotypes and residues K307 and K310 are the most critical residues for binding
                  of 1A1D-2 mAb [
                  <span ref-type="bibr" rid="B54">46</span>, 
                  <span ref-type="bibr" rid="B53">75</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Finally, Shrestha et al. immunized mice with a genotype 2 strain of DENV1 virus and
                  generated 79 new mAbs 16 of which strongly inhibited infection by the homologous virus
                  and localized to DIII of E protein. Surprisingly, only two mAbs, E105 and E106, retained
                  strong binding and neutralizing activity against all five DENV1 genotypes as well
                  as being protective in immunocompromised infected mice. Moreover, E105 and E106 exhibited
                  therapeutic activity even when administered as a single dose four days after inoculation
                  with a heterologous genotype 4 strain of DENV1 in the same mouse model [
                  <span ref-type="bibr" rid="B32">32</span>].
               </p>
            </div>
            <div id="sec2.4.3">
               <h3>2.4.3. Other Non-Human mAbs</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Other non-human and non-murine as well as humanized mAbs directed against the E glycoprotein
                  have been described. In this regard, Goncalvez et al. isolated a large panel of anti-E
                  Fab fragments from chimpanzees infected with all four DENV serotypes. However, only
                  a limited number of them displayed a cross-neutralizing activity against DENV1 and
                  2 and to a lesser extent against DENV3 and 4. In particular, the authors calculated
                  that, among them, the 1A5 mAb that was further humanized, neutralized DENV1–4 at a
                  PRNT50 titer of 0.48, 0.95, 3.2, and 4.3 
                  <i>μ</i>g/mL, respectively. Interestingly, the humanized 1A5 was also tested for binding and
                  neutralization against the WNV/DENV4 chimera, JEV strain SA14-14-2, and Langat virus
                  (LGTV) strain TP 21, giving a PRNT50 titer of 3.8, 21, and 28 
                  <i>μ</i>g/mL, respectively. Moreover, the authors calculated that when administered in a dose
                  of 2 mg per kg of body weight 1A5 would give a serum titer of approximately 40 and
                  20 50% reduction in plaque reduction neutralization test (PRNT50) against DENV1 and
                  DENV2, respectively [
                  <span ref-type="bibr" rid="B55">76</span>]. Furthermore, epitope mapping of 1A5 mAb localized to G106 within the 
                  <i>Flavivirus</i>-conserved fusion loop in DII of DENV2 E protein [
                  <span ref-type="bibr" rid="B56">51</span>].
               </p>
            </div>
            <div id="sec2.4.4">
               <h3>2.4.4. Anti-DENV Human mAbs</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As anticipated, attempts to isolate neutralizing human mAbs have been more challenging
                  due to the restricted elicited Ab-repertoire which recognizes DIII of E glycoprotein
                  in naïve as well as in infected patients [
                  <span ref-type="bibr" rid="B57">77</span>, 
                  <span ref-type="bibr" rid="B58">78</span>]. However, several groups reported the isolation of neutralizing mAbs from infected
                  subjects. In this regard, Setthapramote et al. isolated a total of 136 human hybridoma
                  clones producing specific mAbs against DENV, obtained using PBMCs from nine blood
                  samples from four acute-phase patients secondarily infected with DENV2 and five convalescent-phase
                  patients. Interestingly, the authors found that most of the acute-phase mAb clones
                  were cross-reactive with all four DENV serotypes, with most of them recognizing the
                  E protein and endowing of neutralizing activity against all DENV serotypes, compared
                  to those derived from convalescent-phase patients. In particular, from the acute-phase
                  PBMCs, 81.8% were anti-E, 6.6% were anti-prM, and 3.3% were anti-NS1, while 13.3%
                  anti-E, 13.3% anti-prM, and 53.3% anti-NS1 mAbs clones were obtained from convalescent-phase
                  PBMCs [
                  <span ref-type="bibr" rid="B59">79</span>]. Previous studies confirmed the data obtained by Setthapramote et al. on convalescent-phase
                  patients, but this group firstly reported the efficient preparation of human mAbs
                  with strong neutralizing activity titers against all four DENV serotypes using PBMCs
                  from acute-phase patients secondarily infected with DENV [
                  <span ref-type="bibr" rid="B60">80</span>, 
                  <span ref-type="bibr" rid="B61">81</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The group of de Alwis, through immunoglobulin depletion studies, reported that a substantial
                  fraction of DENV-reactive Abs in human immune sera, including type-specific neutralizing
                  Abs, bound to the intact virion but not to recombinant E protein. The authors confirmed
                  these observations also isolating human neutralizing mAbs and proposed that humans
                  produce Abs that neutralize DENV infection by binding a complex, quaternary structure
                  epitope that is expressed only when E proteins are assembled on a virus particle [
                  <span ref-type="bibr" rid="B62">48</span>]. Similar findings have been described for several other viruses, including WNV and
                  HIV [
                  <span ref-type="bibr" rid="B63">82</span>, 
                  <span ref-type="bibr" rid="B64">83</span>]. Mapping studies indicate that this epitope has a footprint that spans adjacent
                  E protein dimers and includes residues at the hinge between domains I and II of E
                  protein [
                  <span ref-type="bibr" rid="B62">48</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Recently, Costin et al. isolated three broadly neutralizing anti-DENV human mAbs named
                  4.8A, D11C, and 1.6D. These mAbs were isolated from three different convalescent patients
                  with distinct histories of DENV infection. All three mAbs recognized the E glycoprotein
                  with high affinity, neutralized all four serotypes of DENV but mediated ADE of infection
                  in Fc receptor-bearing cells at subneutralizing concentrations. Mapping studies revealed
                  that all three mAbs bind discontinuous epitopes within the highly conserved fusion-loop
                  region of DII (contacting residues W101, L107, and/or G109) [
                  <span ref-type="bibr" rid="B65">37</span>].
               </p>
            </div>
         </div>
         <div id="sec2.5">
            <h3>2.5. Yellow Fever Virus (YFV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The WHO estimates that there are 200,000 cases of yellow fever virus (YFV) infections
               and 30,000 related deaths every year especially in Sub-Saharan Africa. In fact, different
               to the majority of human arboviruses and similarly to DENV and CHIKV, YFV has expanded
               its host range to include humans as an amplifying host [
               <span ref-type="bibr" rid="B1">1</span>]. Symptoms occurring from 3 to 6 days after infection with YFV consist mostly in
               fever, chills, anorexia, lumbosacral pain, nausea, and vomiting. This syndrome lasts
               about 3 days in most cases and is sometimes followed by a one-day lasting period of
               remission. Fever will reoccur together with dark hematemesis, melena, petechiae, and
               other hemorrhagic symptoms. Convalescence is characterized by deep asthenia lasting
               up to two weeks. Rarely, prognosis can be fatal. An effective live-attenuated vaccine
               (17D) derived from the Asibi strain by serial passages in chicken embryos is available
               [
               <span ref-type="bibr" rid="B66">84</span>]. 
            </p>
            <div id="sec2.5.1">
               <h3>2.5.1. mAbs against YFV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In 1983, Schlesinger et al. produced a battery of mAbs after immunization of BALB/c
                  mice by injection of 17D YFV vaccine strain [
                  <span ref-type="bibr" rid="B66">84</span>]. Among them, the specificity towards the E and NS1 proteins was described, even
                  though anti-NS1 Abs were not able to show neutralizing activity. The 13 IgG and 1
                  IgM anti-E protein mAbs were classified in five groups according to their specificity.
                  Group A, consisting of the only IgM produced in this experiment, could neutralize
                  17D YFV virus only; group B 17D and Asibi strains only; group C Asibi strain only;
                  group D could only neutralize Asibi but not 17D strain, showing also reactivity against
                  DENV2, Zika, or Banzi viruses. All of the four mAbs belonging to this group were able
                  to cross-react with Zika and/or Banzi viruses, and two (4E11 and 5H3) neutralized
                  DENV2 virus, with 4E11 neutralizing also Banzi virus. The 3E9 mAb, the only component
                  of the group E, could not neutralize 17D nor Asibi strains.
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">All of the IgG mAbs resulted able to protect both prophylactically and therapeutically
                  BALB/c or CD-1 mice from lethal intracerebral challenge with 17D-204 strain [
                  <span ref-type="bibr" rid="B67">85</span>]. The chimeric form of the group B mAb 2C9 IgG (2C9-cIgG) was able to provide AG129
                  mice a 72% survival when administered 24 hours before infection with 17D-204 strain.
                  Its murine form could provide the survival of the 95% of the mice. Appreciable results
                  were also obtained when both murine 2C9 and 2C9-cIgG were administered 24 hours post-infection,
                  with the survival of 70% and 20% of mice, respectively. Viral presence was not detected
                  in surviving mice [
                  <span ref-type="bibr" rid="B68">60</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In 2005, Daffis and colleagues constructed two Ab-phage libraries by cloning the repertoire
                  of YFV-infected patients. Panning was then performed with YFV-17D virions. The scFv-5A,
                  7A and R3(27) showed a neutralizing activity spanning from 50% to 100% in PRNT assays
                  against both YFV 17D-204-WHO and Asibi strains. In further tests, reactivity was observed
                  against wild-type YFV strains of West Africa genotype I and II (Nigeria 1987 and Asibi
                  strains, resp.), and East/Central Africa (CAR 1986, Ethiopia 1961 strains). A concentration
                  from 0.1 to 0.3 
                  <i>μ</i>g/mL could yield a 90% plaque reduction. Reactivity was also observed against the
                  strain Senegal 1990 in a lesser extent. Production of escape variants could demonstrate
                  that scFv-5A, 7A and R3(27) epitopes are built up by residues extensively separated
                  in the monomers of E glycoprotein, that however result in closed proximity when the
                  homodimeric form of E is constituted [
                  <span ref-type="bibr" rid="B69">61</span>]. 
               </p>
            </div>
         </div>
         <div id="sec2.6">
            <h3>2.6. West Nile Virus (WNV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The West Nile virus (WNV) is an epidemic neurotropic virus estimated to be responsible
               of about 36,000 cases and 1,500 deaths registered in the United States between 1992
               and 2012 [
               <span ref-type="bibr" rid="B70">86</span>]. WNV antigenicity allows its classification into the Japanese encephalitis virus
               (JEV) serocomplex. Genomic analysis has revealed two main genetic lineages of WNV:
               lineage I viruses, circulating in the USA, Europe, the Middle East, Africa, India,
               and Australia, and lineage II viruses, isolated from Sub-Saharan Africa and Madagascar
               [
               <span ref-type="bibr" rid="B1">1</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNV was firstly identified in 1937 and is endemic in many countries of Africa, Middle
               East and West Asia. However, after 1990 frequent outbreaks of WNV infections were
               reported in Romania, Israel and later in North America and across the USA in 1999
               and recently, in 2012 [
               <span ref-type="bibr" rid="B71">87</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Most of WNV infected individuals do not develop symptoms while about 20% develop a
               self-limiting illness called West Nile fever. Acute symptoms include fever, tiredness
               and swollen lymph glands but in a minority of cases also encephalitis with long-term
               deficits in cognitive function and motor skills have been reported. However, in less
               than 1% of infected patients, WNV having crossed the blood-brain barrier, is responsible
               of neuroinvasive and potentially lethal form of the disease. In these cases, degeneration
               and apoptosis upon infection of neurons and the consequent inflammatory response can
               occur. Related symptoms include high fever, coma, muscle weakness, and paralysis.
               Immunodepression and advanced age have been correlated with an augment risk to develop
               a severe disease [
               <span ref-type="bibr" rid="B71">87</span>]. There are no specific treatment options or licensed vaccines for humans [
               <span ref-type="bibr" rid="B72">88</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WNV is transmitted by infected mosquitos and initial replication is thought to occur
               primarily in dendritic cells in the skin, which migrate to secondary lymphoid tissues
               where the replicating virus enters the circulation. To date, only efficacious WNV
               veterinarian vaccines have been licensed, while there are no licensed vaccines for
               protection against WNV in humans [
               <span ref-type="bibr" rid="B72">88</span>]. 
            </p>
            <div id="sec2.6.1">
               <h3>2.6.1. mAbs against WNV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Broad-spectrum antivirals, such as type I IFN-
                  <i>α</i>, ribavirin, mycophenolic acid, in WNV infection showed ineffective results 
                  <i>in vivo</i> despite 
                  <i>in vitro</i> they showed some activity [
                  <span ref-type="bibr" rid="B73">89</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">However, experiments in murine models, extrapolation of clinical data as well as passive
                  administration of pooled immune-
                  <i>γ</i>-globulins (OmriGam), containing a significant titer of neutralizing Abs, before and
                  after infection, showed an important role of the humoral immune response in controlling
                  viremia and prevent viral dissemination. Indeed, the development of a neutralizing
                  mAb-based therapy seems to be encouraging for a possible treatment of infected patients
                  [
                  <span ref-type="bibr" rid="B74">90</span>–
                  <span ref-type="bibr" rid="B76">92</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Similarly to what has been observed for DENV, only anti-E Abs have been identified
                  as neutralizing and protective. Also anti-NS1 Abs have shown a protective role, however,
                  their mechanism of protection has not yet been elucidated, as the NS1 protein is secreted
                  from infected cells and not present on the virions [
                  <span ref-type="bibr" rid="B77">93</span>–
                  <span ref-type="bibr" rid="B79">95</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In this regard, similarly to what has been described for DENV, studies performed using
                  a naïve human scFv library for panning with purified WNV E protein, support the hypothesis
                  that no Abs against the neutralizing DIII can be isolated. However, DIII specific
                  Abs were isolated in a subsequent study using immunoglobulin libraries obtained from
                  three WNV infected patients for biopanning on purified inactivated virus, virus-like
                  particles consisting of prM and E proteins or recombinant E glycoprotein. Although
                  the proportion of DIII-specific mAbs was low (8%) compared with anti-DII mAbs (47%).
                  Two out of the four anti-DIII mAbs were potently neutralizing and protective 
                  <i>in vivo</i>, whereas only three out of the 24 anti-DII were weakly neutralizing 
                  <i>in vitro</i> and non-protective 
                  <i>in vivo</i>. In particular, residues that are critical for neutralization lies on the regions
                  spanning amino acids 305–312, 330–333, and 365 that are located on adjacent exposed
                  loops of DIII. However, sequence alignment of E protein of different 
                  <i>flaviviruses</i>, such as DENV and JEV, revealed a considerable variation compared to the whole E
                  protein. This observation further suggests that differently from broadly cross-reactive
                  anti-DII Abs, anti-DIII neutralizing Abs are virus-type specific. However, of these
                  mAbs, two (CR4374 and CR4353) protected mice from lethal WNV challenge at 50% protective
                  doses of 12.9 and 357 
                  <i>μ</i>g/kg of body weight, respectively [
                  <span ref-type="bibr" rid="B80">50</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sánchez et al., using three different immunization strategies (i.e., inactivated virus,
                  naked DNA, and recombinant protein), isolated nine murine mAbs, most of which bound
                  to conformation-dependent epitopes in DIII of the E protein. In particular, neutralizing
                  mAbs, named 8B10, 11C2, 10C5, and 17C8, were obtained from mice immunized with inactivated
                  virus alone or in combination with a DNA plasmid and bound to the same region of DIII
                  with high affinity. In contrast, mAbs obtained by immunization with a soluble version
                  of the E glycoprotein did not exhibit neutralizing activity. These non-neutralizing
                  mAbs were cross-reactive with several other 
                  <i>flaviviruses</i>, including SLEV, JEV, YFV, and Powassan virus, confirming the conserved nature of
                  
                  <i>Flavivirus</i> non-neutralizing epitopes [
                  <span ref-type="bibr" rid="B81">96</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gould et al., isolated 11 unique human single-chain variable region Ab fragments (scFvs)
                  that bind the E protein of WNV. Among them, a human mAb, named mAb11, expressed as
                  a scFv-Fc fusion protein was further characterized. It recognizes the fusion loop,
                  at the distal end of DII of the WNV E protein and cross-reacts with all four DENV
                  serotypes, and provides protection against DENV2 and 4 as well as WNV [
                  <span ref-type="bibr" rid="B82">42</span>]. Moreover, therapeutic studies of this mAb in WNV-infection model mice provided
                  substantial protection when administered after 5 days post-infection. Interestingly,
                  a neutralization escape variant of this mAb failed to cause lethal encephalitis (at
                  higher infectious doses) or induce the inflammatory responses associated with blood-brain
                  barrier permeability in mice, compared to the parental WNV, suggesting an important
                  role for the fusion loop in viral pathogenesis [
                  <span ref-type="bibr" rid="B83">43</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oliphant et al., isolated an anti-DIII E protein mAb, named E16, from hybridomas obtained
                  after immunization of mice with recombinant WNV E protein, which neutralized all WNV
                  strains with PRNT50 values of 4 to 18 ng and PRNT90 values of 53 to 297 ng. One hundred
                  micrograms of mAb protected greater than 90% of mice from lethal infection and even
                  a single 4 
                  <i>μ</i>g treatment of E16 on day 2 after infection prevented mortality. Moreover, humanization
                  of this mAb confirmed as therapeutically effective in mice [
                  <span ref-type="bibr" rid="B84">44</span>]. Subsequent studies revealed that mAb E16 neutralization is mediated by engagement
                  of four discontinuous segments of DIII including the amino-terminal region (amino
                  acid residues 302–309) and the three connecting loops BC (amino acid residues 330–333),
                  DE (amino acid residues 365–368), and FG (amino acid residues 389–391). Moreover,
                  no ADE of infection was detected when E16 mAb was used at saturating concentrations
                  [
                  <span ref-type="bibr" rid="B85">45</span>, 
                  <span ref-type="bibr" rid="B86">47</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Furthermore, results of a Phase I safety study of the humanized E16 mAb (designated
                  MGAWN1) have been reported and suggested that doses of up to 30 mg/kg were well tolerated
                  with few mild adverse events and would provide an excess of virus neutralizing activity
                  for 3-4 weeks after treatment. However, a case of anti-MGAWN1 Ab elicitation occurred
                  with the consequent increased rate of clearance and indeed impacting efficacy. A Phase
                  II safety and efficacy study of MGAWN1 is ongoing [
                  <span ref-type="bibr" rid="B87">97</span>]. Furthermore, the possibility of preventing or treating WNV-induced memory deficits
                  was recently investigated. In this study, hamsters were treated intraperitoneally
                  with 32 mg/kg of MGAWN1 mAb at 4.5 days after subcutaneously challenging with WNV.
                  Interestingly, MGAWN1 prevented mortality, weight loss and improved food consumption
                  of WNV-infected hamsters compared to controls [
                  <span ref-type="bibr" rid="B88">98</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Recently, Lelli et al. isolated six anti-E mAbs from inactivated-WNV immunized mice.
                  In particular, three of them (3B2, 3D6 and 4D3) neutralized lineage I and II WNV,
                  with the first two recognizing the same epitopes located on the distal lateral surface
                  of DIII (critical amino acid residue K307). Conversely, 4D3 mAb recognized a novel
                  neutralizing epitope on DII (critical residues S276 and T278). Indeed, further protective
                  and therapeutic studies are needed to ascertain their neutralizing activity 
                  <i>in vivo </i>[
                  <span ref-type="bibr" rid="B89">99</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Finally, to conclude, like DENV infection, Abs directed against the M protein are
                  not protective and neutralizing. Moreover, in humans, a skewed humoral immune response
                  against DII has been frequently observed and confirmed also with the hybridoma technology
                  [
                  <span ref-type="bibr" rid="B80">50</span>]. The isolation and elicitation of neutralizing Abs directed against the fusion loop
                  and DIII of the E protein represent thus the most challenging and promising goal for
                  the development of new effective therapeutic inhibitors and immunogens, respectively.
                  
               </p>
            </div>
         </div>
         <div id="sec2.7">
            <h3>2.7. Tick-Borne Encephalitis Virus (TBEV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tick-borne encephalitis virus (TBEV) is one of the most dangerous agents causing human
               neuroinfections, occurring mostly in Europe and Asia, and with a potential fatal prognosis
               [
               <span ref-type="bibr" rid="B90">100</span>]. TBEV is believed to cause 3,500–10,000 human cases of encephalitis in Europe per
               year, with a high morbidity in Russia, Czech Republic, Austria, and Germany. In particular,
               between 1990 and 2007, an average of 8,755 cases of TBE was reported per year in Europe
               and Russia. Despite the fact that Russia is the country with most infections registered
               annually, Czech Republic incidence is among the highest in Europe, with 400–1,000
               clinical cases reported every year [
               <span ref-type="bibr" rid="B91">101</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Three subtypes of TBEV are classified, namely, European, Siberian, and Far-Eastern,
               sharing most of the genetic and antigenic features [
               <span ref-type="bibr" rid="B92">102</span>]. In fact, a high degree of antigenic homogeneity between different strains of TBEV
               has been described [
               <span ref-type="bibr" rid="B93">103</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clinical manifestations vary among the subtypes, but usually they start with a short
               febrile period of 7–14 days after the tick bite. Fatigue, headache, and pain in the
               neck, shoulders, and lower back, together with high fever and vomiting may be present
               [
               <span ref-type="bibr" rid="B90">100</span>]. These manifestations are often followed by an asymptomatic phase lasting from 2
               to 10 days after remission from the fever, with possible progression to neurological
               disease. Neurological symptoms include meningitis, encephalitis, myelitis, and radiculitis.
               Mortality occurs in 1-2% of the European subtype-infected patients, but fatal prognosis
               can occur in up to 20–40% of the Far-Eastern subtype-infected patients [
               <span ref-type="bibr" rid="B94">104</span>]. Mortality rates of the Siberian subtype are similar to those observed for the European
               [
               <span ref-type="bibr" rid="B95">105</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effective and safe vaccines against TBEV produced from inactivated virus have been
               developed and licensed for their use in humans. However, an emergency therapy in the
               absence of a mass immunization is needed as no effective treatments are yet available
               [
               <span ref-type="bibr" rid="B96">106</span>].
            </p>
            <div id="sec2.7.1">
               <h3>2.7.1. mAbs against TBEV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Levanov et al. described the chimerization of two murine mAbs (13D6 and 10C2) directed
                  against the DIII and DII, respectively, of the TBEV E glycoprotein. The chimeric mAbs
                  present binding characteristics similar to the parental mAbs. Moreover, as the parental
                  mAbs, only the chimeric mAb 13D6 was able to neutralize TBEV infectivity 
                  <i>in vitro</i>. In particular, neutralization studies with the murine, chimeric, and scFv forms
                  of mAb 13D6 were performed. In particular, murine 13D6 showed an IC50 titer of 11.5 
                  <i>μ</i>g/mL in Focus Reduction Neutralization Tests (FRNT) against TBEV strain 205 and of
                  2.9 
                  <i>μ</i>g/mL in PRNT against TBEV strain Softjin. Chimeric 13D6 showed an IC50 titer of 4.5 
                  <i>μ</i>g/mL in FRNT against TBEV strain 205 and of 1.9 
                  <i>μ</i>g/mL in PRNT against TBEV strain Softjin. ScFv 13D6 showed an IC50 titer of 16.7 
                  <i>μ</i>g/mL in FRNT against TBEV strain 205 and of 11.2 
                  <i>μ</i>g/mL in PRNT against TBEV strain Softjin [
                  <span ref-type="bibr" rid="B97">62</span>].
               </p>
            </div>
         </div>
         <div id="sec2.8">
            <h3>2.8. Japanese Encephalitis Virus (JEV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Japanese encephalitis virus (JEV) is a mosquito-borne 
               <i>flavivirus</i> that over the past few decades has caused several outbreaks throughout China, Southeast
               Asia, Australia, and Papua New Guinea with a prevalence recently estimated to be of
               about 70,000 cases/year [
               <span ref-type="bibr" rid="B98">107</span>–
               <span ref-type="bibr" rid="B100">109</span>]. A 40% mortality was recorded in some of the JEV-affected areas. Moreover, many
               survivors face some neurological problems and complications [
               <span ref-type="bibr" rid="B99">108</span>]. Since 1995, the disease has also emerged in Non-Asian regions such as Northern
               Australia [
               <span ref-type="bibr" rid="B101">110</span>, 
               <span ref-type="bibr" rid="B102">111</span>]. The situation in Southeast Asia, however, is further complicated by the overlapping
               epidemics of JEV and DENV as well as sporadic cases of WNV infections detected in
               some of the affected areas particularly in India [
               <span ref-type="bibr" rid="B103">112</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effective vaccines, both live-attenuated and inactivated strains of JEV, have been
               developed and licensed in major countries. However, as for the other arthropod-borne
               
               <i>Flavivirus</i> members, no specific antiviral drugs are currently available [
               <span ref-type="bibr" rid="B4">4</span>]. 
            </p>
            <div id="sec2.8.1">
               <h3>2.8.1. mAbs against JEV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As previously described for the other 
                  <i>Flavivirus</i> members, many groups isolated and characterized anti-JEV mAbs showing different neutralizing
                  and protective properties. In this regard, Gupta et al. used combinations of anti-E
                  JEV mAbs (Hs1-4) in mice protection experiments. In particular, they found that the
                  singularly mAb protection ranged from 45 to 65% when 100 
                  <i>μ</i>g of mAb were administered, while equimolar combinations of two or three mAbs gave
                  85–90% or 100% protection, respectively [
                  <span ref-type="bibr" rid="B104">113</span>]. In similar experiments, Lee et al. demonstrated that a 
                  <i>Flavivirus</i> anti-NS1 mAb, named 16NS1, cross-reacted with JEV as well as WNV and exhibited protective
                  activity against WNV as well as a lethal JEV infection. However, no neutralizing activity
                  was observed using this mAb against both WNV and JEV in 
                  <i>in vitro</i> experiments, suggesting the participation of other Ab-mediated mechanisms 
                  <i>in vivo</i>. In particular, 95% of mice were protected when 500 
                  <i>μ</i>g of mAb were administered intraperitoneally and concomitantly to intramuscular injection
                  of JEV. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Overlapping peptide mapping analysis combined with site-specific mutations identified
                  the 
                  <sup>116</sup>KAWGKSILFA
                  <sup>125</sup> region and critical amino acid residues, W118 and I122, as 16NS1 mAb epitope, highly
                  conserved in WNV and JEV strains [
                  <span ref-type="bibr" rid="B105">114</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arakawa et al. isolated from a combinatorial human Fab library constructed from peripheral
                  blood lymphocytes obtained from JEV hyperimmune volunteers. Among 188 randomly selected
                  clones, FabTJE12B02 showed the best 50% focus reduction endpoint at the concentration
                  of 50.2 
                  <i>μ</i>g/mL against the JEV strain Nakayama [
                  <span ref-type="bibr" rid="B106">55</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Goncalvez et al. isolated three mAbs, named Fabs A3, B2, and E3, by repertoire cloning
                  from chimpanzees initially immunized with inactivated JE-VAX and then boosted with
                  attenuated JEV SA14-14-2. In particular, these mAbs reacted with epitopes in three
                  different E domains: in DI (amino acid residue K179), in DII (I126), and in DIII (G132)
                  for Fabs A3, B2, and E3, respectively. Moreover, these Fabs as well as the derived
                  humanized counterpart mAbs exhibited high neutralizing activities against a broad
                  spectrum of JEV genotype strains. Moreover, these mAbs exhibited a 50% protective
                  dose of 0.84 
                  <i>μ</i>g (B2), 5.8 
                  <i>μ</i>g (A3), and 24.7 
                  <i>μ</i>g (E3) in mouse models. Finally, administration of 200 
                  <i>μ</i>g/mouse of mAb B2 one day after otherwise lethal JEV infection protected 50% of mice
                  and significantly prolonged the average survival time compared to that of mice in
                  the unprotected group [
                  <span ref-type="bibr" rid="B107">54</span>].
               </p>
            </div>
         </div>
         <div id="sec2.9">
            <h3>2.9. St. Louis Encephalitis Virus (SLEV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">St. Louis encephalitis virus (SLEV) was first discovered as the mosquito-borne agent
               responsible for over 1,000 cases of encephalitis during a 1933 summer outbreak in
               St. Louis (Missouri) and now is a reemerging human pathogen widely distributed in
               the American continent, causing several human encephalitis outbreaks over the last
               80 years. Additional epidemics have indeed occurred from 1964 to 2006 in the Americas,
               ranging from the US to Argentina and Brazil. As a member of the 
               <i>Flavivirus</i> genus, the SLEV E glycoprotein ectodomain is 68% identical to serocomplex-related
               JEV E but only 46% and 40% identical to those of DENV2 and TBEV, viruses from different
               serocomplexes [
               <span ref-type="bibr" rid="B108">115</span>].
            </p>
            <div id="sec2.9.1">
               <h3>2.9.1. mAbs against SLEV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In 1983, Roehrig et al. isolated twenty-one hybridomas producing murine mAbs specific
                  for the E glycoprotein of SLEV, strain MSI-7. Serologic reactivities were initially
                  determined by cross-reactivity indirect immunofluorescence assays using 22 strains
                  of SLEV and 8 other related 
                  <i>flaviviruses</i>. Four groups demonstrating type-, subcomplex-, supercomplex-, and group-specific
                  reactivity patterns were identified. Analysis of hemagglutination-inhibition and virus
                  neutralization subdivided the cross-reactivity groups into eight epitopes (E-1a, b,
                  c, d, E-2, E-3, and E-4a, b), one of them following localized in DII (4b) [
                  <span ref-type="bibr" rid="B109">52</span>, 
                  <span ref-type="bibr" rid="B110">53</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Moreover, among the previously described isolated anti-WNV mAbs by Gould et al., the
                  chimeric scFv-Fc 79, effectively neutralized also SLEV, resulting in &gt;80% of PRNT80
                  when used at 5 
                  <i>μ</i>g/mL [
                  <span ref-type="bibr" rid="B82">42</span>].
               </p>
            </div>
         </div>
      </div>
      <div id="sec3">
         <h2>3. 
            <i>Alphaviruses </i>
         </h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Major human arboviruses in the Togaviridae family, Chikungunya (CHIKV) and Venezuelan
            equine encephalomyelitis (VEEV) viruses, belong to the 
            <i>Alphavirus</i> genus, which is composed of viruses with an icosahedral nucleocapsid surrounded by
            a lipid envelope and glycoprotein spikes. The structural proteins of 
            <i>alphaviruses</i> arise through co- and post-translational processing of a polyprotein encoded by a
            single, positive-stranded RNA producing the capsid (C), PE2, 6 K, and E1. The PE2
            glycoprotein is a precursor containing the E3 glycoprotein fused to the amino terminus
            of the E2 envelope glycoprotein. The PE2 glycoprotein is followed by 6 K, a small
            membrane-associated protein, and E1, the second polypeptide component of glycoprotein
            spikes.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trimerized heterodimers of the E1 and E2 viral glycoproteins form the surface spikes
            and contain determinants of viral tropism and virulence. The E3 glycoprotein acts
            as a signal for transport of PE2 across the membranes of the rough endoplasmic reticulum
            and may promote the formation and intracellular transport of E1-PE2 heterodimers to
            the cell surface. During transport to the cell surface, PE2 undergoes a maturational
            cleavage event by a furin-like protease to produce E2 and E3 [
            <span ref-type="bibr" rid="B111">116</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The E2 glycoprotein promotes specificity of virus binding to the host cell surface
            and is a target of the humoral immune response. The E1 glycoprotein mediates fusion
            of the virion envelope with the membranes of acidified endosomes, allowing release
            of the nucleocapsid into the cytoplasm and the onset of viral replication. 
            <i>Alphavirus</i> E1 shares no appreciable sequence identity to 
            <i>Flavivirus</i> E protein. Despite differences in their amino acid sequences and arrangements on
            the viral particle, the structures of E and E1 are remarkably similar. Indeed, the
            conservation of three domains has been well documented in crystal structures of 
            <i>flavivirus</i> E ectodomains from TBEV, DENV, JEV, and WNV, as well as 
            <i>Alphavirus</i> E1 from Semliki Forest virus (SFV) and CHIKV. Abs to the E1 glycoprotein do not typically
            neutralize virus infectivity 
            <i>in vitro</i> but can protect against lethal challenge in animals. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">By analogy with the prM protein of dengue 
            <i>Flavivirus</i>, furin cleavage of PE2 may begin after transit of an acidic late component of the
            Golgi body, where E3 is thought to suppress the acid pH-triggered activation of glycoprotein
            E1 fusion capability. Protective anti-E3 mouse mAbs have also been described [
            <span ref-type="bibr" rid="B112">117</span>]. 
         </p>
         <div id="sec3.1">
            <h3>3.1. Chikungunya Virus (CHIKV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The chikungunya virus (CHIKV) belongs to the Semliki Forest clade and was firstly
               isolated in 1953 in Tanzania during an epidemic outbreak, following occurred also
               in Asia and Africa. In the last five decades, several CHIKV outbreaks have been described
               both in Africa and Asia separated by gaps lasting from two to twenty years. In 2005-2006,
               about 300,000 cases out of 785,000 inhabitants were reported in La Réunion island,
               with a fatal prognosis for 237 of the patients [
               <span ref-type="bibr" rid="B112">117</span>]. Neither Europe nor the Americas have had outbreaks of CHIKV so far, except for
               imported isolated cases. Three genotypes of CHIKV are described: Asian, East/Central/South
               African (ECSA), and West African, with an amino acid identity spanning from 95.2%
               to 99.8%. Recent epidemics in Africa and Indian subcontinent were caused by strains
               belonging to the ECSA genotype. Transmitted by 
               <i>Aedes</i> mosquitoes, CHIKV is maintained in the human population by human-mosquito-human transmission
               [
               <span ref-type="bibr" rid="B1">1</span>]. The disease is characterized by dengue-like symptoms such as chills, high fever,
               headache, and persistent myalgia and a further incapacitating arthralgia (from which
               the name chikungunya) which affects 40% of infected subjects. However, prognosis is
               rarely fatal [
               <span ref-type="bibr" rid="B111">116</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">There is currently no commercial vaccine and antiviral treatment for CHIKV, although
               some candidate vaccines have been tested in humans. In this regard, in 2000 US Army
               performed a Phase II clinical trial testing a live-attenuated CHIKV vaccine (TSI-GSD-218)
               derived from a 1962 strain (15561) of an outbreak in Thailand. Out of 58, every patient
               developed neutralizing Abs, and 5 lamented mild to moderate joint pain [
               <span ref-type="bibr" rid="B112">117</span>]. A phase III trial of this candidate vaccine is ongoing. Furthermore, a new formulation
               using virus-like particles was able to induce neutralizing Abs in macaques against
               different CHIKV strains [
               <span ref-type="bibr" rid="B112">117</span>, 
               <span ref-type="bibr" rid="B113">118</span>]. Indeed, it has been described that infection seems to elicit long-lasting protective
               immunity and cross-protection among CHIKV and other 
               <i>alphaviruses</i>.
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHIKV entry into host cell is demonstrated to be mediated by envelope glycoproteins
               E1 and E2, which allow virus fusion to cell membrane in low pH conditions and recognition
               of an unknown cellular receptor, respectively [
               <span ref-type="bibr" rid="B111">116</span>, 
               <span ref-type="bibr" rid="B114">119</span>–
               <span ref-type="bibr" rid="B116">121</span>]. Even though the genome replication relies on an error-prone RNA-dependent RNA-polymerasis,
               CHIKV strains S27 and 05.115 Reunion showed in E1 and E2 a low amino acid variation
               of 0.68% and 3.3%, respectively, and such a low variability may be needed for an effective
               replication in two phylogenetically distant hosts [
               <span ref-type="bibr" rid="B111">116</span>, 
               <span ref-type="bibr" rid="B117">122</span>]. Recently, the crystal structure of E1 and E2 heterodimer has been resolved both
               at low pH and natural conditions, shedding light on E1 and E2 ectodomains' structure.
               In particular, similarly to 
               <i>flaviviruses</i> E protein, E1 ectodomain is made of the N-terminal DI, the DII containing the fusion
               loop, and the DIII at the C-terminal. On the other hand, E2 ectodomain comprises the
               N-terminal domain A, the domain B supposed to interact with the host cell's unknown
               receptor, and domain C at the C-terminal. E1 DIII and E2 domain C are located close
               to the viral membrane [
               <span ref-type="bibr" rid="B118">123</span>, 
               <span ref-type="bibr" rid="B119">124</span>].
            </p>
            <div id="sec3.1.1">
               <h3>3.1.1. mAbs against CHIKV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Warter et al. described 5F10 and 8B10, two human mAbs which strongly neutralized several
                  CHIKV isolates 
                  <i>in vitro</i>, without cross-reactivity against other 
                  <i>alphaviruses</i> but to Onyong-nyong virus [
                  <span ref-type="bibr" rid="B120">56</span>]. Mixed preparation of 5F10 and 8F10 did not show neither synergistic nor addictive
                  effect 
                  <i>in vitro</i>, and studies upon escape mutants demonstrated that 5F10 mAb binds at the tip of the
                  E2 domain B, while 8B10 recognizes residues close to E1 fusion loop and amino acids
                  within E2 domain A, which form a transitional epitope under low pH conditions. The
                  authors speculated that 5F10 and 8B10 may inhibit CHIKV entry and fusion to the cell
                  membrane, respectively. It is worth noting that the previously mentioned escape mutants
                  displayed mutations associated with reduced viral fitness 
                  <i>in vitro</i> even after 13 neutralization/amplification rounds. In the same study, cell-to-cell
                  transmission was firstly demonstrated as an escape mechanism, enhanced by the E2 mutation
                  R82G [
                  <span ref-type="bibr" rid="B117">122</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In further 
                  <i>in vivo</i> studies, 5F10 and 8B10 significantly delayed CHIKV-caused death of AGR129 mice both
                  in prophylactic and therapeutic tests. Interestingly, in therapeutic treatment, these
                  mAbs showed a synergistic effect when administered in combination, with the total
                  amount of mAbs injected being the same of the single-mAbs. Possibly, these treatment
                  did not allow the mice to survive CHIKV challenge due to Ig clearing and 6–10 days
                  half-life usually described for human mAbs [
                  <span ref-type="bibr" rid="B121">125</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Recently, Pal et al. cloned thirty-six murine mAbs able to neutralize the ECSA La
                  Reunion 2006 OPY-1 strain of CHIKV (CHIKV-LR), the majority of which also neutralize
                  infection of other strains corresponding to the Asian and West African genotypes.
                  In particular, mAb CHK-152 showed the highest and broadest neutralizing activity,
                  with FRNT values indicating an IC50 value of 1 to 3 ng/mL depending on the viral strain
                  used. Among the thirty-six mAbs, four (CHK-102, CHK-152, and CHK-166, CHK-263) could
                  prevent lethality of immunodeficient
                  <i> Ifnar−/−</i> C57BL/6 mice when administered one day before exposition, with CHK-152 and CHK-263
                  showing the ability to protect mice at the lowest dose (10 
                  <i>μ</i>g). Therapeutic studies were performed on these mAbs administering a single dose of
                  100 
                  <i>μ</i>g 24 hours after infection. The highest activity was described for CHK-166, able to
                  protect 63% of the mice. Testing the combined activity of the mAbs in therapeutic
                  studies, administration of CHK-166 plus CHK-152 in a dose of 250 
                  <i>μ</i>g each turned out to be the most effective, protecting 71% of the 
                  <i>Ifnar−/−</i> C57BL/6 mice 60 hours after infection [
                  <span ref-type="bibr" rid="B122">57</span>].
               </p>
            </div>
         </div>
         <div id="sec3.2">
            <h3>3.2. Venezuelan Equine Encephalomyelitis Virus (VEEV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Venezuelan equine encephalomyelitis virus (VEEV) is maintained in a natural transmission
               cycle between mosquitoes and small rodents. The first documented outbreaks occurred
               in the 1930s, and several epidemics have been reported so far in Latin-American countries
               such as Venezuela, Colombia, Peru, Ecuador, Bolivia, Honduras, Mexico, and Panama
               with hundreds of thousands of human cases being reported and a case-fatality rate
               up to 1% during the 1969 Ecuador outbreak. Clinical manifestations of VEE are indistinguishable
               from Dengue [
               <span ref-type="bibr" rid="B123">126</span>]. Six serogroups (I–VI) are currently recognized within the VEEV complex. VEEV caused
               human and equine outbreaks in the Americas for nearly a century. Equine epizootics
               have high mortality (38–83%) leading to a high viremia followed by a lethal encephalitis
               and often to human epidemics involving thousands of cases and hundreds of deaths.
               Indeed, VEEV is infectious for humans by the airborne route and has been responsible
               for a number of laboratory infections. In humans, the disease is usually self-limiting
               with a febrile illness with 1–4% of cases progressing to severe encephalitis. It is
               a hazard to laboratory workers, has been developed as a biological weapon, and is
               a potential bioterrorist agent [
               <span ref-type="bibr" rid="B124">127</span>]. There are no antiviral drugs and vaccines licensed for the treatment of VEEV infection
               in humans. Indeed, although experimental live-attenuated vaccines have been developed
               (e.g., TC-83) with good levels of protection in equine and mice, in humans they may
               fail to give protection in the majority of cases [
               <span ref-type="bibr" rid="B125">128</span>]. Considering the protective role exerted by humoral immune response in animal models,
               it could be concluded that treatment with specific IgG may have a beneficial antiviral
               effect in human airborne infections with pathogenic strains of VEEV.
            </p>
            <div id="sec3.2.1">
               <h3>3.2.1. mAbs against VEEV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Several works support that mAbs may protect against airborne VEEV as well as after
                  airborne exposure to VEEV. Ab reactivity to both surface glycoproteins (E1 and E2)
                  is associated with neutralization of the virus 
                  <i>in vitro</i> and passive protection against virus challenge. A series of anti-E1 and anti-E2 mouse
                  and humanized mAbs have been described recently. Among them, Phillpotts et al. examined
                  two anti-E2 murine mAbs, named 1A4A-1 and 1A3A-9, both having potent protective activity
                  against subcutaneous VEEV challenge in mice. Both mAbs had a similar half-life (5.8
                  and 10.0 days) in mouse serum after a single intraperitoneal dose, suggesting that
                  mAbs, delivered by this route at or around the time of VEEV infection, persists at
                  high levels in the blood as well as secretions in respiratory transudation throughout
                  the clinical course of the disease. In particular both mAbs, administered 24 h prior
                  to airborne challenges had a substantial protective effect (90–100%). Treatment of
                  mice, 2 or 24 h after airborne infection, with a single intraperitoneal dose of 100 
                  <i>μ</i>g of 1A3A-9 mAb, led to approximately 50% survival. There was no beneficial effect
                  when mAb treatment was delayed to 72 h. Moreover, there was evidence of synergy 
                  <i>in vitro</i> in PRNT, between 1A3A-9 and 1A4A-1, as has been demonstrated for other viruses and
                  mAb pairs. However, no synergy was found in mouse protection when mAbs were delivered
                  intraperitoneally as a mixture in equal parts, to animals challenged 24 h previously
                  with VEEV [
                  <span ref-type="bibr" rid="B126">129</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In a subsequent study Phillpotts et al. reported two other protective mAbs. The 3B2A-9
                  mAb protected against all the serogroup I strains while 1A3B-7 mAb protected well
                  against challenge with all of the viruses tested. Both 3B2A-9 and 1A3B-7 protected
                  against airborne exposure to the IA/B serogroup virus strain Trinidad donkey (TrD).
                  However, there was no evidence of synergistic protection when these mAbs were combined
                  in equal proportions. An intraperitoneal dose of 10 
                  <i>μ</i>g was sufficient to protect 50% of the mice with either mAb [
                  <span ref-type="bibr" rid="B127">130</span>]. According to other data, the mechanism of protection did not appear to depend upon
                  neutralization [
                  <span ref-type="bibr" rid="B128">131</span>]. Similar results were obtained by O'Brien et al., which described a non-neutralizing
                  mAb (IgG2a), named CUF37-2a, able to protect 50% of mice from a subcutaneous VEEV
                  challenge when a dose of 9.15 
                  <i>μ</i>g of mAb was administered 24 h prior to challenge [
                  <span ref-type="bibr" rid="B129">132</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In a following study the 1A3B-7 mAb was humanized (and following reported as Hu1A3B-7)
                  maintaining the same features of its murine counterpart. In particular, evaluation
                  of 
                  <i>in vitro</i> studies indicated that Hu1A3B-7 retained both broad specificity and neutralizing
                  activity. Furthermore, 
                  <i>in vivo</i> experiments showed that Hu1A3B-7 successfully protected mice against lethal subcutaneous
                  and aerosol challenges with VEEV strain TrD. Moreover, the effectiveness of the humanization
                  process was determined by assessing proliferation responses in human T-cells to peptides
                  derived from the murine and humanized versions of the VH and VL domains. This analysis
                  showed that the number of human T-cell epitopes within the humanized Ab had been substantially
                  reduced, indicating that Hu1A3B-7 may have low immunogenicity 
                  <i>in vivo </i>[
                  <span ref-type="bibr" rid="B130">133</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Similarly, Hunt et al. described a humanized murine mAb derived from the 3B4C-4 mAb,
                  recognizing the E2c epitope (amino acid residues 182–209) and following named Hy4-26C,
                  showing neutralizing activity similar to the murine mAb. Moreover, it was protective
                  (70–100% of survival) at 100 ng dose in mice animal model intraperitoneal inoculated
                  and at 500 
                  <i>μ</i>g for intranasal challenge (80%). Therapeutic studies in mice revealed that Hy4-26C
                  was able to cure mice up to 24 h following infection at 10 
                  <i>μ</i>g, on the contrary the mouse mAb when given 1 hour after virus challenge [
                  <span ref-type="bibr" rid="B131">63</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In another work, Hunt et al. isolated two neutralizing humanized Fabs, F5 and L1A7,
                  employing a blocking strategy [
                  <span ref-type="bibr" rid="B132">134</span>, 
                  <span ref-type="bibr" rid="B133">135</span>]. The anti-E2 specific F5 IgG had a 70% PRNT endpoint of 10 ng/mL, equivalent to
                  that described for the most effective neutralizing anti-VEEV E2 mAbs. In particular,
                  the E1-specific hFab L1A7 had a PRNT endpoint of 3 
                  <i>μ</i>g/mL, 300-fold lower than F5. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Further studies revealed that F5 epitope is located in the 115–199 amino acid region.
                  Moreover F5 IgG had potent ability to protect mice from infection by either route
                  when administered 24 h before exposure; however, mice treated 24 h and 48 h after
                  aerosol exposure developed central nervous system infections but exhibited no clinical
                  signs of disease [
                  <span ref-type="bibr" rid="B133">135</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hu et al. reported that passive immunization with the humanized chimeric mouse mAb
                  hu1A4A1IgG1-2A in mice at 50 
                  <i>μ</i>g 24 h before or after virulent VEEV challenge provided complete protection, indicating
                  that hu1A4A1IgG1-2A has potent prophylactic and therapeutic effects against VEEV infection
                  [
                  <span ref-type="bibr" rid="B134">136</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Anti-VEEV mAbs isolated from a non-human primate gene library has also been reported.
                  In particular the humanized chimeric scFv-Fc ToR67-3B4 recognized viable as well as
                  formalin and 
                  <i>β</i>-propiolactone inactivated virus particles. It detected specifically the viral E1
                  envelope protein of VEEV but did not react with reduced viral glycoprotein preparations
                  suggesting that recognition depends upon conformational epitopes. The recombinant
                  Ab was able to detect multiple VEEV subtypes and displayed only marginal cross-reactivity
                  to other 
                  <i>Alphavirus</i> species except for Eastern equine encephalitis virus (EEEV). In addition, the scFv-Fc
                  fusion described here might be of therapeutic use since it successfully inactivated
                  VEEV in a murine disease model. In particular, when the recombinant Ab was administered
                  6 hours after challenge, 80% to 100% of mice survived lethal VEEV IA/B or IE infection.
                  Forty to sixty percent of mice survived when scFv-Fc ToR67-3B4 was applied 6 hours
                  after challenge with VEEV subtypes II and former IIIA [
                  <span ref-type="bibr" rid="B135">137</span>].
               </p>
            </div>
         </div>
      </div>
      <div id="sec4">
         <h2>4. Bunyaviridae</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The Bunyaviridae family contains human arboviruses belonging to the 
            <i>Orthobunyavirus</i>, 
            <i>Phlebovirus</i>, and 
            <i>Nairovirus</i> genera. Bunyaviridae includes enveloped viruses with a fragmented, single-stranded
            RNA genome of negative polarity. Their tripartite genome consists of a small (S),
            a medium (M), and a large (L) fragment and the envelope glycoproteins Gn and Gc that
            are cleaved out of a polyprotein synthesized by the M fragment. These glycoproteins
            have been proved to mediate the formation of the virus particle, to play a role in
            the interaction with cell surface receptors, to mediate the entry of the virus into
            cells, and to serve as targets for the majority of neutralizing Abs described so far.
            
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
            <i>Orthobunyavirus</i>, transmitted through mosquitoes or midges vectors, are divided in 18 serogroups,
            based on cross-titrations in haemagglutination inhibition assays and neutralization
            assays, and correlating with main vector preferences. However, the most clinically
            important viruses belong only to two serogroups, the California encephalitis and the
            Simbu serogroups.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Crimean-Congo hemorrhagic fever virus (CCHFV) is considered the only one of clinical
            relevance within the 
            <i>Nairovirus</i> genus, which uses tick as main vector and is divided in seven serogroups, while Toscana
            virus and Rift Valley fever virus (RVFV), which are transmitted by sandflies and mosquitoes,
            respectively, belong to the 
            <i>Phlebovirus</i> genus [
            <span ref-type="bibr" rid="B136">138</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAbs against the 
            <i>Nairovirus</i> CCHFV and the 
            <i>Phlebovirus</i> RVFV have been described.
         </p>
         <div id="sec4.1">
            <h3>4.1. Crimean-Congo Hemorrhagic Fever Virus (CCHFV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Crimean-Congo Hemorrhagic Fever Virus (CCHFV) distribution covers the greatest geographic
               range of any tick-borne virus known, as viral isolation and/or disease has been reported
               from more than 30 countries in Southeastern Europe, Africa, Asia, and Middle East
               [
               <span ref-type="bibr" rid="B137">139</span>, 
               <span ref-type="bibr" rid="B138">140</span>]. Namely, from 1953 to 2010, about 6,000 human cases were reported in Southeastern
               Europe. CCHFV causes sporadic outbreaks with mortality rates ranging from 10 to 80%
               [
               <span ref-type="bibr" rid="B139">141</span>, 
               <span ref-type="bibr" rid="B140">142</span>]. A significant variation in the time of incubation has been described [
               <span ref-type="bibr" rid="B137">139</span>]. Prehemorrhagic symptoms include high fever, chills, headache, photophobia, and
               back and abdominal pains. Among other symptoms, neuropsychiatric changes have been
               reported in some patients. In severe cases, 3–6 days after the onset of the disease,
               hemorrhagic symptoms occur with petechiae, ecchymosis, bleeding in the form of melena,
               hematemesis, epistaxis [
               <span ref-type="bibr" rid="B137">139</span>].
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In comparison with the nucleocapsid proteins, in CCHFV Gn and Gc show a higher degree
               of antigenic variability probably due to their exposition to the host immune system,
               hypothesis corroborated in the description by Hewson et al. in 2004 of four M segment
               phylogenic groups, namely, M1, M2, M3, and M4 [
               <span ref-type="bibr" rid="B139">141</span>, 
               <span ref-type="bibr" rid="B140">142</span>].
            </p>
            <div id="sec4.1.1">
               <h3>4.1.1. mAbs against CCHFV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Blackburn et al. firstly described in 1987 murine anti-CCHFV mAbs able to recognize
                  nucleocapsid proteins, but no neutralizing activity has been described thus far [
                  <span ref-type="bibr" rid="B141">143</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">On the other hand, Bertolotti-Ciarlet et al. produced a panel of murine mAbs recognizing
                  conformational epitopes within the Gn and Gc glycoproteins expressed by the CCHFV
                  strain IbAr10200. The effectiveness of the mAbs was studied by performing PRNT80 and
                  none of the anti-Gn mAbs showed neutralizing activity, although many of the anti-Gc
                  mAbs neutralized IbAr10200 strain 
                  <i>in vitro</i> with clones 8A1, 5E3, 12A9, 6C2, and 9H3 showing activity at a &gt;5120 dilution. MAbs
                  11E7 and 30F7 exhibited neutralizing activity at 2560 dilution. A suckling mice protection
                  test was therefore performed for these mAbs. The previously mentioned anti-Gc Abs
                  were capable to protect mice to an appreciable degree when applied 24 hours before
                  and, in a weaker manner, 24 hours after virus challenge. Many of the anti-Gn mAbs
                  were able to confer significant protection to IbAr10200 both 24 hours before and after
                  virus administration. The relevant effectiveness of the anti-Gn mAbs 6B12, 10E11,
                  13G8, and 10G4 suggests that these mAbs may possess some neutralizing activity due
                  to Ab-based effector mechanisms (e.g., ADCC) [
                  <span ref-type="bibr" rid="B142">58</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In further studies, the same group characterized the broadly cross-reactive neutralizing
                  activity of the previously described murine mAb 11E7, able to bind conformational
                  epitopes within the C-terminal region of the Gn glycoprotein of all CCHFV M groups
                  [
                  <span ref-type="bibr" rid="B142">58</span>, 
                  <span ref-type="bibr" rid="B139">141</span>].
               </p>
            </div>
         </div>
         <div id="sec4.2">
            <h3>4.2. Rift Valley Fever Virus (RVFV)</h3>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Similarly to CCHFV, Rift Valley Fever Virus (RVFV) causes sporadic outbreaks. The
               largest epidemic occurred in Egypt in 1977, with an estimated 200,000 infections,
               18,000 patients manifesting symptoms and 600 fatal prognoses [
               <span ref-type="bibr" rid="B143">144</span>]. Symptoms include hemorrhagic episodes, fever, encephalitis, and blindness [
               <span ref-type="bibr" rid="B144">145</span>]. 
            </p>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The major target of the humoral immune response is the RVFV glycoproteins Gc (G1)
               and Gn (G2), ranging from nucleotides 480–2090 and 2091–3614, respectively [
               <span ref-type="bibr" rid="B143">144</span>]. 
            </p>
            <div id="sec4.2.1">
               <h3>4.2.1. mAbs against RVFV</h3>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Within G2 glycoprotein are described three neutralizing antigenic sites, namely, epitope
                  I: nucleotides 792–893 (amino acid residues 258–291); epitope II: nucleotides 1164–1196
                  (amino acid residues 382–392); and epitope IV: nucleotides 858–917 (amino acid residues
                  280–299) [
                  <span ref-type="bibr" rid="B145">59</span>, 
                  <span ref-type="bibr" rid="B144">145</span>]. 
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Despite the high degree of variability observed in CCHFV glycoproteins, RVFV G2 presented
                  an unexpected high conservation among 22 isolates [
                  <span ref-type="bibr" rid="B145">59</span>]. In the same study, only the LUNYO and 900060 isolates were resistant to 
                  <i>in vitro</i> neutralization by murine mAb 4D4 (recognizing epitope II). All other isolates were
                  neutralized with PRNT80 titers from 10,240 to &gt;81,920. On the other hand, only SNS
                  isolate showed reduced sensitivity to 4–39-CC (epitope IV). All other isolates were
                  neutralized with PRNT80 titers from 20,480 to &gt;81,920. Protection studies on mice
                  would be of interest for the development of a passive immunization prophylaxis [
                  <span ref-type="bibr" rid="B145">59</span>].
               </p>
               <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Protection studies from lethal South African RVFV AN1830 strain infection were successfully
                  performed on a battery of anti-G1 and anti-G2 mAbs produced by Besselaar and Blackburn,
                  with the strongly neutralizing anti-G1 mAb 3E5 and anti-G2 mAb 9C4 being the most
                  effective [
                  <span ref-type="bibr" rid="B146">146</span>]. The 9C4 antigenic area maps within G2 epitope I, and a broadly neutralizing activity
                  may be investigated.
               </p>
            </div>
         </div>
      </div>
      <div id="sec5">
         <h2>5. Conclusions</h2>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arbovirus infections have acquired increasing interest given the augmented globalization
            and tourism movement all over the world that could be at the basis of epidemic events.
            Furthermore, the same vectors can sometimes transmit several arboviruses concomitantly,
            complicating the diagnosis as well as the therapy. For example, confusing mixed epidemics
            have occasionally been described, such as YFV plus CHIKV, DENV plus CHIKV, or more
            recently 
            <i>Plasmodium falciparum</i> malaria plus DENV1 and CHIKV on Madagascar's east coast [
            <span ref-type="bibr" rid="B1">1</span>].
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In the last decade, several efforts have been employed in the development of effective
            immunogens and therapeutics giving the current absence of specific antiviral drugs
            as well as effective vaccines for the most diffused arbovirus infections (i.e., DENV
            and WNV).
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">However, at the moment, mosquito control is the best available method for preventing
            arbovirus infections. Thus, to control the emerging public health problem of arbovirus
            infections, new antiviral therapeutic strategies that provide potent, and broadly
            cross-protective immunity (especially for 
            <i>flavivirus</i> infections) are an urgent globally medical need.
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">As described in this review the majority of highly neutralizing mAbs are of murine
            origin and indeed their utility in the treatment of these infections is limited. In
            fact, their employment can elicit an immunogenic response (i.e., human anti-mouse
            Abs, HAMA), the therapeutic efficacy could be reduced by a relatively faster clearance
            in humans (compared to human Abs), potentially exacerbated by the HAMA response. Finally,
            murine Abs exhibit relatively weak effector functions (e.g., ADCC) compared to human
            Abs. Indeed, chimerization, humanization, or better, the isolation and characterization
            of fully human broadly neutralizing mAbs would be the best choice for their possible
            use in a future mAb-based therapy against arbovirus infections [
            <span ref-type="bibr" rid="B147">147</span>]. 
         </p>
         <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Finally, possible ADE of infection mechanisms should be evaluated before considering
            a mAb as a possible candidate therapeutic in a post-exposure setting as well as in
            the development of new Ab-eliciting immunogens.
         </p>
      </div>
      <div tagxxx="back">
         <div tagxxx="ack">
            <div tagxxx="title">Conflict of Interests</div>
            <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The authors declare no conflict of interests, in particular, with OmriGam and any
               other cited Ab-based preparation mentioned in the paper.
            </p>
         </div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <div tagxxx="label">1</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Cleton</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Koopmans</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Reimerink</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Godeke</span>
                           <span tagx="given-names">GJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Reusken</span>
                           <span tagx="given-names">C</span>
                        </div>
                     </div>
                     <span tagx="article-title">Come fly with me: review of clinically important arboviruses for global travelers</span>
                     <span tagx="source">
                        <i>Journal of Clinical Virology</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">55</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">191</span>
                     <span tagx="lpage">203</span>
                     <div tagxxx="pub-id">22840968</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">2</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Heinz</span>
                           <span tagx="given-names">FX</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Holzmann</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Essl</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kundi</span>
                           <span tagx="given-names">M</span>
                        </div>
                     </div>
                     <span tagx="article-title">Field effectiveness of vaccination against tick-borne encephalitis</span>
                     <span tagx="source">
                        <i>Vaccine</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">25</span>
                     <div tagxxx="issue">43</div>
                     <span tagx="fpage">7559</span>
                     <span tagx="lpage">7567</span>
                     <div tagxxx="pub-id">2-s2.0-34848839208</div>
                     <div tagxxx="pub-id">17869389</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">3</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Barrett</span>
                           <span tagx="given-names">AD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Teuwen</span>
                           <span tagx="given-names">DE</span>
                        </div>
                     </div>
                     <span tagx="article-title">Yellow fever vaccine—how does it work and why do rare cases of serious adverse events
                        take place?
                     </span>
                     <span tagx="source">
                        <i>Current Opinion in Immunology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">21</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">308</span>
                     <span tagx="lpage">313</span>
                     <div tagxxx="pub-id">2-s2.0-67049086866</div>
                     <div tagxxx="pub-id">19520559</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">4</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Halstead</span>
                           <span tagx="given-names">SB</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Thomas</span>
                           <span tagx="given-names">SJ</span>
                        </div>
                     </div>
                     <span tagx="article-title">New vaccines for Japanese encephalitis</span>
                     <span tagx="source">
                        <i>Current Infectious Disease Reports</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">12</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">174</span>
                     <span tagx="lpage">180</span>
                     <div tagxxx="pub-id">21308526</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">5</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Perotti</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">M</span>
                        </div>
                     </div>
                     <span tagx="article-title">Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV
                        drugs
                     </span>
                     <span tagx="source">
                        <i>Journal of Hepatology</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">49</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">299</span>
                     <span tagx="lpage">300</span>
                     <div tagxxx="pub-id">2-s2.0-46149124765</div>
                     <div tagxxx="pub-id">18554744</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">6</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Diotti</span>
                           <span tagx="given-names">RA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sautto</span>
                           <span tagx="given-names">GA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Solforosi</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                     </div>
                     <span tagx="article-title">Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived
                        from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein
                     </span>
                     <span tagx="source">
                        <i>New Microbiologica</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">35</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">475</span>
                     <span tagx="lpage">479</span>
                     <div tagxxx="pub-id">23109015</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">7</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Canducci</span>
                           <span tagx="given-names">F</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Molecular cloning of the first human monoclona antibodies neutralizing with high potency
                        Swine-origin Influenza A pandemic virus (S-OIV)
                     </span>
                     <span tagx="source">
                        <i>New Microbiologica</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">32</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">319</span>
                     <span tagx="lpage">324</span>
                     <div tagxxx="pub-id">2-s2.0-74249110309</div>
                     <div tagxxx="pub-id">20128437</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">8</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Chandra</span>
                           <span tagx="given-names">PK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hazari</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Poat</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits
                        replication of highly efficient hepatitis C Virus 2a clone
                     </span>
                     <span tagx="source">
                        <i>Virology Journal</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">7, article 118</span>
                     <div tagxxx="pub-id">2-s2.0-77953080993</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">9</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">de Marco</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A human monoclonal antibody with neutralizing activity against highly divergent influenza
                        subtypes
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">12</div>
                     <div tagxxx="pub-id">2-s2.0-82955194795</div>
                     <div tagxxx="pub-id">e28001</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">10</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">de Marco</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against
                        H1N1 and H5N1 viruses
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">4</div>
                     <div tagxxx="pub-id">2-s2.0-84859364851</div>
                     <div tagxxx="pub-id">e34415</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">11</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Solforosi</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Canducci</span>
                           <span tagx="given-names">F</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A phage display vector optimized for the generation of human antibody combinatorial
                        libraries and the molecular cloning of monoclonal antibody fragments
                     </span>
                     <span tagx="source">
                        <i>New Microbiologica</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">35</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">289</span>
                     <span tagx="lpage">294</span>
                     <div tagxxx="pub-id">22842598</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">12</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Koonin</span>
                           <span tagx="given-names">EV</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dolja</span>
                           <span tagx="given-names">VV</span>
                        </div>
                     </div>
                     <span tagx="article-title">Evolution and taxonomy of positive-strand RNA viruses: implications of comparative
                        analysis of amino acid sequences
                     </span>
                     <span tagx="source">
                        <i>Critical Reviews in Biochemistry and Molecular Biology</i>
                     </span>
                     <span tagx="year">1993</span>
                     <span tagx="volume">28</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">375</span>
                     <span tagx="lpage">430</span>
                     <div tagxxx="pub-id">2-s2.0-0027504136</div>
                     <div tagxxx="pub-id">8269709</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">13</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mackenzie</span>
                           <span tagx="given-names">JS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gubler</span>
                           <span tagx="given-names">DJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Petersen</span>
                           <span tagx="given-names">LR</span>
                        </div>
                     </div>
                     <span tagx="article-title">Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile
                        and dengue viruses
                     </span>
                     <span tagx="source">
                        <i>Nature Medicine</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">10</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">S98</span>
                     <span tagx="lpage">S109</span>
                     <div tagxxx="pub-id">2-s2.0-10944252079</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">14</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">TJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Brandt</span>
                           <span tagx="given-names">WE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Swanson</span>
                           <span tagx="given-names">JL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">McCown</span>
                           <span tagx="given-names">JM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Buescher</span>
                           <span tagx="given-names">EL</span>
                        </div>
                     </div>
                     <span tagx="article-title">Physical and biological properties of dengue-2 virus and associated antigens</span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1970</span>
                     <span tagx="volume">5</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">524</span>
                     <span tagx="lpage">532</span>
                     <div tagxxx="pub-id">2-s2.0-0014771068</div>
                     <div tagxxx="pub-id">4195055</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">15</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Smit</span>
                           <span tagx="given-names">JM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Moesker</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rodenhuis-Zybert</span>
                           <span tagx="given-names">I</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wilschut</span>
                           <span tagx="given-names">J</span>
                        </div>
                     </div>
                     <span tagx="article-title">Flavivirus cell entry and membrane fusion</span>
                     <span tagx="source">
                        <i>Viruses</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">3</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">160</span>
                     <span tagx="lpage">171</span>
                     <div tagxxx="pub-id">2-s2.0-79952140351</div>
                     <div tagxxx="pub-id">22049308</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">16</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Kuhn</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">W</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rossmann</span>
                           <span tagx="given-names">MG</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Structure of dengue virus: implications for flavivirus organization, maturation, and
                        fusion
                     </span>
                     <span tagx="source">
                        <i>Cell</i>
                     </span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">108</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">717</span>
                     <span tagx="lpage">725</span>
                     <div tagxxx="pub-id">2-s2.0-18344387519</div>
                     <div tagxxx="pub-id">11893341</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">17</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Stiasny</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Aberle</span>
                           <span tagx="given-names">JH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Keller</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Grubeck-Loebenstein</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Heinz</span>
                           <span tagx="given-names">FX</span>
                        </div>
                     </div>
                     <span tagx="article-title">Age affects quantity but not quality of antibody responses after vaccination with
                        an inactivated flavivirus vaccine against tick-borne encephalitis
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">3</div>
                     <div tagxxx="pub-id">2-s2.0-84858841502</div>
                     <div tagxxx="pub-id">e34145</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">18</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Thomas</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Verlaeten</span>
                           <span tagx="given-names">O</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Cabié</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Influence of the dengue serotype, previous dengue infection, and plasma viral load
                        on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic
                     </span>
                     <span tagx="source">
                        <i>American Journal of Tropical Medicine and Hygiene</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">78</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">990</span>
                     <span tagx="lpage">998</span>
                     <div tagxxx="pub-id">2-s2.0-47049119952</div>
                     <div tagxxx="pub-id">18541782</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">19</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">Y</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Corver</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Chipman</span>
                           <span tagx="given-names">PR</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Structures of immature flavivirus particles</span>
                     <span tagx="source">
                        <i>EMBO Journal</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">22</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">2604</span>
                     <span tagx="lpage">2613</span>
                     <div tagxxx="pub-id">2-s2.0-0038201461</div>
                     <div tagxxx="pub-id">12773377</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">20</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Falconar</span>
                           <span tagx="given-names">AKI</span>
                        </div>
                     </div>
                     <span tagx="article-title">Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective
                        monoclonal antibodies: design of an improved epitope sequence based on common determinants
                        present in both envelope (E and M) proteins
                     </span>
                     <span tagx="source">
                        <i>Archives of Virology</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">144</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">2313</span>
                     <span tagx="lpage">2330</span>
                     <div tagxxx="pub-id">2-s2.0-0033394257</div>
                     <div tagxxx="pub-id">10664386</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">21</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Huang</span>
                           <span tagx="given-names">K-J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Yang</span>
                           <span tagx="given-names">Y-C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lin</span>
                           <span tagx="given-names">Y-S</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">The dual-specific binding of dengue virus and target cells for the antibody-dependent
                        enhancement of dengue virus infection
                     </span>
                     <span tagx="source">
                        <i>Journal of Immunology</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">176</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">2825</span>
                     <span tagx="lpage">2832</span>
                     <div tagxxx="pub-id">2-s2.0-33644549138</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">22</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Falconar</span>
                           <span tagx="given-names">AKI</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1
                        glycoprotein during live dengue virus infections in mice and humans: implications
                        for diagnosis, pathogenesis, and vaccine design
                     </span>
                     <span tagx="source">
                        <i>Clinical and Vaccine Immunology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">14</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">493</span>
                     <span tagx="lpage">504</span>
                     <div tagxxx="pub-id">2-s2.0-34250346479</div>
                     <div tagxxx="pub-id">17329445</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">23</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mandl</span>
                           <span tagx="given-names">CW</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Guirakhoo</span>
                           <span tagx="given-names">F</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Holzmann</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Heinz</span>
                           <span tagx="given-names">FX</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kunz</span>
                           <span tagx="given-names">C</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antigenic structure of the flavivirus envelope protein E at the molecular level, using
                        the tick-borne encephalitis virus as a model
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1989</span>
                     <span tagx="volume">63</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">564</span>
                     <span tagx="lpage">571</span>
                     <div tagxxx="pub-id">2-s2.0-0024548815</div>
                     <div tagxxx="pub-id">2463377</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">24</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Rey</span>
                           <span tagx="given-names">FA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Heinz</span>
                           <span tagx="given-names">FX</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mandl</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kunz</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Harrison</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">1995</span>
                     <span tagx="volume">375</span>
                     <div tagxxx="issue">6529</div>
                     <span tagx="fpage">291</span>
                     <span tagx="lpage">298</span>
                     <div tagxxx="pub-id">2-s2.0-0029014434</div>
                     <div tagxxx="pub-id">7753193</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">25</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Allison</span>
                           <span tagx="given-names">SL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Stiasny</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Stadler</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mandl</span>
                           <span tagx="given-names">CW</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Heinz</span>
                           <span tagx="given-names">FX</span>
                        </div>
                     </div>
                     <span tagx="article-title">Mapping of functional elements in the stem-anchor region of tick-borne encephalitis
                        virus envelope protein E
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">73</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">5605</span>
                     <span tagx="lpage">5612</span>
                     <div tagxxx="pub-id">2-s2.0-0032989258</div>
                     <div tagxxx="pub-id">10364309</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">26</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Klein</span>
                           <span tagx="given-names">DE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Choi</span>
                           <span tagx="given-names">JL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Harrison</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Structure of a dengue virus envelope protein late-stage fusion intermediate</span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">87</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">2287</span>
                     <span tagx="lpage">2293</span>
                     <div tagxxx="pub-id">23236058</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">27</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hanna</span>
                           <span tagx="given-names">SL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pierson</span>
                           <span tagx="given-names">TC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sanchez</span>
                           <span tagx="given-names">MD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ahmed</span>
                           <span tagx="given-names">AA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Murtadha</span>
                           <span tagx="given-names">MM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Doms</span>
                           <span tagx="given-names">RW</span>
                        </div>
                     </div>
                     <span tagx="article-title">N-linked glycosylation of West Nile virus envelope proteins influences particle assembly
                        and infectivity
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">79</span>
                     <div tagxxx="issue">21</div>
                     <span tagx="fpage">13262</span>
                     <span tagx="lpage">13274</span>
                     <div tagxxx="pub-id">2-s2.0-27144498110</div>
                     <div tagxxx="pub-id">16227249</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">28</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sautto</span>
                           <span tagx="given-names">G</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Neutralization interfering antibodies: a, “novel” example of humoral immune dysfunction
                        facilitating viral escape?
                     </span>
                     <span tagx="source">
                        <i>Viruses</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">4</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">1731</span>
                     <span tagx="lpage">1752</span>
                     <div tagxxx="pub-id">23170181</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">29</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Modis</span>
                           <span tagx="given-names">Y</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ogata</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clements</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Harrison</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Variable surface epitopes in the crystal structure of dengue virus type 3 envelope
                        glycoprotein
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">79</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">1223</span>
                     <span tagx="lpage">1231</span>
                     <div tagxxx="pub-id">2-s2.0-11144244755</div>
                     <div tagxxx="pub-id">15613349</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">30</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Miller</span>
                           <span tagx="given-names">N</span>
                        </div>
                     </div>
                     <span tagx="article-title">Recent progress in dengue vaccine research and development</span>
                     <span tagx="source">
                        <i>Current Opinion in Molecular Therapeutics</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">12</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">31</span>
                     <span tagx="lpage">38</span>
                     <div tagxxx="pub-id">20140814</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">31</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Chávez</span>
                           <span tagx="given-names">JH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Silva</span>
                           <span tagx="given-names">JR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Amarilla</span>
                           <span tagx="given-names">AA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Moraes Figueiredo</span>
                           <span tagx="given-names">LT</span>
                        </div>
                     </div>
                     <span tagx="article-title">Domain III peptides from flavivirus envelope protein are useful antigens for serologic
                        diagnosis and targets for immunization
                     </span>
                     <span tagx="source">
                        <i>Biologicals</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">38</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">613</span>
                     <span tagx="lpage">618</span>
                     <div tagxxx="pub-id">2-s2.0-78650236701</div>
                     <div tagxxx="pub-id">20817489</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">32</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Shrestha</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Brien</span>
                           <span tagx="given-names">JD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sukupolvi-Petty</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">The development of therapeutic antibodies that neutralize homologous and heterologous
                        genotypes of dengue virus type 1
                     </span>
                     <span tagx="source">
                        <i>PLoS Pathogens</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">4</div>
                     <div tagxxx="pub-id">e1000823</div>
                     <div tagxxx="pub-id">2-s2.0-77953922252</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">33</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Gromowski</span>
                           <span tagx="given-names">GD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Barrett</span>
                           <span tagx="given-names">ND</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Barrett</span>
                           <span tagx="given-names">ADT</span>
                        </div>
                     </div>
                     <span tagx="article-title">Characterization of dengue virus complex-specific neutralizing epitopes on envelope
                        protein domain III of dengue 2 virus
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">82</span>
                     <div tagxxx="issue">17</div>
                     <span tagx="fpage">8828</span>
                     <span tagx="lpage">8837</span>
                     <div tagxxx="pub-id">2-s2.0-50149096815</div>
                     <div tagxxx="pub-id">18562544</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">34</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Sukupolvi-Petty</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Austin</span>
                           <span tagx="given-names">SK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Purtha</span>
                           <span tagx="given-names">WE</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Type- and subcomplex-specific neutralizing antibodies against domain III of dengue
                        virus type 2 envelope protein recognize adjacent epitopes
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">81</span>
                     <div tagxxx="issue">23</div>
                     <span tagx="fpage">12816</span>
                     <span tagx="lpage">12826</span>
                     <div tagxxx="pub-id">2-s2.0-36348963709</div>
                     <div tagxxx="pub-id">17881453</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">35</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Sukupolvi-Petty</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Austin</span>
                           <span tagx="given-names">SK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Engle</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Structure and function analysis of therapeutic monoclonal antibodies against dengue
                        virus type 2
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">84</span>
                     <div tagxxx="issue">18</div>
                     <span tagx="fpage">9227</span>
                     <span tagx="lpage">9239</span>
                     <div tagxxx="pub-id">2-s2.0-77956031215</div>
                     <div tagxxx="pub-id">20592088</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">36</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Deng</span>
                           <span tagx="given-names">Y-Q</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dai</span>
                           <span tagx="given-names">J-X</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ji</span>
                           <span tagx="given-names">G-H</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel
                        epitope within the fusion loop of e protein
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">1</div>
                     <div tagxxx="pub-id">2-s2.0-79251586520</div>
                     <div tagxxx="pub-id">e16059</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">37</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Costin</span>
                           <span tagx="given-names">JM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Zaitseva</span>
                           <span tagx="given-names">E</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kahle</span>
                           <span tagx="given-names">KM</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue
                        virus that target the fusion loop
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">87</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">52</span>
                     <span tagx="lpage">66</span>
                     <div tagxxx="pub-id">23077306</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">38</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Midgley</span>
                           <span tagx="given-names">CM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Flanagan</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Tran</span>
                           <span tagx="given-names">HB</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Structural analysis of a dengue cross-reactive antibody complexed with envelope domain
                        III reveals the molecular basis of cross-reactivity
                     </span>
                     <span tagx="source">
                        <i>Journal of Immunology</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">188</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">4971</span>
                     <span tagx="lpage">4979</span>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">39</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Moreland</span>
                           <span tagx="given-names">NJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Susanto</span>
                           <span tagx="given-names">P</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lim</span>
                           <span tagx="given-names">E</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Phage display approaches for the isolation of monoclonal antibodies against dengue
                        virus envelope domain III from human and mouse derived libraries
                     </span>
                     <span tagx="source">
                        <i>International Journal of Molecular Sciences</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">13</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">2618</span>
                     <span tagx="lpage">2635</span>
                     <div tagxxx="pub-id">2-s2.0-84858959575</div>
                     <div tagxxx="pub-id">22489114</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">40</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Cockburn</span>
                           <span tagx="given-names">JJB</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Navarro Sanchez</span>
                           <span tagx="given-names">ME</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Fretes</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody</span>
                     <span tagx="source">
                        <i>Structure</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">20</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">303</span>
                     <span tagx="lpage">314</span>
                     <div tagxxx="pub-id">2-s2.0-84856689479</div>
                     <div tagxxx="pub-id">22285214</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">41</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Rajamanonmani</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nkenfou</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clancy</span>
                           <span tagx="given-names">P</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes</span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">90</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">799</span>
                     <span tagx="lpage">809</span>
                     <div tagxxx="pub-id">2-s2.0-65549085229</div>
                     <div tagxxx="pub-id">19264660</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">42</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Gould</span>
                           <span tagx="given-names">LH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sui</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Foellmer</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Protective and herapeutic capacity of human single-chain Fv-Fc fusion proteins against
                        West Nile virus
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">79</span>
                     <div tagxxx="issue">23</div>
                     <span tagx="fpage">14606</span>
                     <span tagx="lpage">14613</span>
                     <div tagxxx="pub-id">2-s2.0-27744601405</div>
                     <div tagxxx="pub-id">16282460</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">43</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Sultana</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Foellmer</span>
                           <span tagx="given-names">HG</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Neelakanta</span>
                           <span tagx="given-names">G</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Fusion Loop Peptide of the West Nile virus envelope protein is essential for pathogenesis
                        and is recognized by a therapeutic cross-reactive human monoclonal antibody
                     </span>
                     <span tagx="source">
                        <i>Journal of Immunology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">183</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">650</span>
                     <span tagx="lpage">660</span>
                     <div tagxxx="pub-id">2-s2.0-68949129068</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">44</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Oliphant</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Engle</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nybakken</span>
                           <span tagx="given-names">GE</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Development of a humanized monoclonal antibody with therapeutic potential against
                        West Nile virus
                     </span>
                     <span tagx="source">
                        <i>Nature Medicine</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">11</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">522</span>
                     <span tagx="lpage">530</span>
                     <div tagxxx="pub-id">2-s2.0-21044448356</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">45</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Nybakken</span>
                           <span tagx="given-names">GE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Oliphant</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Johnson</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Burke</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Diamond</span>
                           <span tagx="given-names">MS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Fremont</span>
                           <span tagx="given-names">DH</span>
                        </div>
                     </div>
                     <span tagx="article-title">Structural basis of West Nile virus neutralization by a therapeutic antibody</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">437</span>
                     <div tagxxx="issue">7059</div>
                     <span tagx="fpage">764</span>
                     <span tagx="lpage">769</span>
                     <div tagxxx="pub-id">2-s2.0-26944454471</div>
                     <div tagxxx="pub-id">16193056</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">46</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Gromowski</span>
                           <span tagx="given-names">GD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Diamond</span>
                           <span tagx="given-names">MS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">JC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pitcher</span>
                           <span tagx="given-names">TJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Barrett</span>
                           <span tagx="given-names">ADT</span>
                        </div>
                     </div>
                     <span tagx="article-title">Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope
                        glycoprotein exploited for neutralization escape
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">407</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">237</span>
                     <span tagx="lpage">246</span>
                     <div tagxxx="pub-id">2-s2.0-77957665570</div>
                     <div tagxxx="pub-id">20832836</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">47</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bolin</span>
                           <span tagx="given-names">RA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kelly</span>
                           <span tagx="given-names">RG</span>
                        </div>
                     </div>
                     <span tagx="article-title">Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica</span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">1998</span>
                     <span tagx="volume">246</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">317</span>
                     <span tagx="lpage">328</span>
                     <div tagxxx="pub-id">2-s2.0-0032486594</div>
                     <div tagxxx="pub-id">9657950</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">48</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">de Alwis</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">SA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Olivarez</span>
                           <span tagx="given-names">NP</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Identification of human neutralizing antibodies that bind to complex epitopes on dengue
                        virions
                     </span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">109</span>
                     <div tagxxx="issue">19</div>
                     <span tagx="fpage">7439</span>
                     <span tagx="lpage">7444</span>
                     <div tagxxx="pub-id">22499787</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">49</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Austin</span>
                           <span tagx="given-names">SK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dowd</span>
                           <span tagx="given-names">KA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Shrestha</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Structural basis of differential neutralization of DENV-1 genotypes by an antibody
                        that recognizes a cryptic epitope
                     </span>
                     <span tagx="source">
                        <i>PLoS Pathogens</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">8</span>
                     <div tagxxx="issue">10</div>
                     <div tagxxx="pub-id">e1002930</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">50</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Throsby</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Geuijen</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goudsmit</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Isolation and characterization of human monoclonal antibodies from individuals infected
                        with West Nile Virus
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">80</span>
                     <div tagxxx="issue">14</div>
                     <span tagx="fpage">6982</span>
                     <span tagx="lpage">6992</span>
                     <div tagxxx="pub-id">2-s2.0-33745767275</div>
                     <div tagxxx="pub-id">16809304</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">51</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Goncalvez</span>
                           <span tagx="given-names">AP</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Purcell</span>
                           <span tagx="given-names">RH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lai</span>
                           <span tagx="given-names">C-J</span>
                        </div>
                     </div>
                     <span tagx="article-title">Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes
                        dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop
                        of the dengue type 2 virus envelope glycoprotein
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">78</span>
                     <div tagxxx="issue">23</div>
                     <span tagx="fpage">12919</span>
                     <span tagx="lpage">12928</span>
                     <div tagxxx="pub-id">2-s2.0-8644255116</div>
                     <div tagxxx="pub-id">15542644</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">52</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mathews</span>
                           <span tagx="given-names">JH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Trent</span>
                           <span tagx="given-names">DW</span>
                        </div>
                     </div>
                     <span tagx="article-title">Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus
                        using monoclonal antibodies
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">1983</span>
                     <span tagx="volume">128</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">118</span>
                     <span tagx="lpage">126</span>
                     <div tagxxx="pub-id">2-s2.0-0020565814</div>
                     <div tagxxx="pub-id">6192585</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">53</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Staudinger</span>
                           <span tagx="given-names">LA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hunt</span>
                           <span tagx="given-names">AR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mathews</span>
                           <span tagx="given-names">JH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Blair</span>
                           <span tagx="given-names">CD</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antibody prophylaxis and therapy for flavivirus encephalitis infections</span>
                     <span tagx="source">
                        <i>Annals of the New York Academy of Sciences</i>
                     </span>
                     <span tagx="year">2001</span>
                     <span tagx="volume">951</span>
                     <span tagx="fpage">286</span>
                     <span tagx="lpage">297</span>
                     <div tagxxx="pub-id">2-s2.0-0035686863</div>
                     <div tagxxx="pub-id">11797785</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">54</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Goncalvez</span>
                           <span tagx="given-names">AP</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Chien</span>
                           <span tagx="given-names">C-H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Tubthong</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Humanized monoclonal antibodies derived from chimpanzee fabs protect against Japanese
                        encephalitis virus in vitro and in vivo
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">82</span>
                     <div tagxxx="issue">14</div>
                     <span tagx="fpage">7009</span>
                     <span tagx="lpage">7021</span>
                     <div tagxxx="pub-id">2-s2.0-47049117135</div>
                     <div tagxxx="pub-id">18480437</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">55</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Arakawa</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Yamashiro</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Uechi</span>
                           <span tagx="given-names">G-I</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Tadano</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nishizono</span>
                           <span tagx="given-names">A</span>
                        </div>
                     </div>
                     <span tagx="article-title">Construction of human Fab (
                        <i>γ</i>1/
                        <i>κ</i>) library and identification of human monoclonal Fab possessing neutralizing potency
                        against Japanese encephalitis virus
                     </span>
                     <span tagx="source">
                        <i>Microbiology and Immunology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">51</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">617</span>
                     <span tagx="lpage">625</span>
                     <div tagxxx="pub-id">2-s2.0-34250873272</div>
                     <div tagxxx="pub-id">17579273</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">56</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Warter</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">CY</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Thiagarajan</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization
                        potency
                     </span>
                     <span tagx="source">
                        <i>Journal of Immunology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">186</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">3258</span>
                     <span tagx="lpage">3264</span>
                     <div tagxxx="pub-id">2-s2.0-79952773018</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">57</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Pal</span>
                           <span tagx="given-names">P</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dowd</span>
                           <span tagx="given-names">KA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Brien</span>
                           <span tagx="given-names">JD</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Development of a highly protective combination monoclonal antibody therapy against
                        chikungunya virus
                     </span>
                     <span tagx="source">
                        <i>PLoS Pathogens</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">9</span>
                     <div tagxxx="issue">4</div>
                     <div tagxxx="pub-id">e1003312</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">58</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Bertolotti-Ciarlet</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Smith</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Strecker</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic
                        fever virus glycoproteins
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">79</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">6152</span>
                     <span tagx="lpage">6161</span>
                     <div tagxxx="pub-id">2-s2.0-20944442102</div>
                     <div tagxxx="pub-id">15858000</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">59</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Battles</span>
                           <span tagx="given-names">JK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Dalrymple</span>
                           <span tagx="given-names">JM</span>
                        </div>
                     </div>
                     <span tagx="article-title">Genetic variation among geographic isolates of Rift Valley fever virus</span>
                     <span tagx="source">
                        <i>American Journal of Tropical Medicine and Hygiene</i>
                     </span>
                     <span tagx="year">1988</span>
                     <span tagx="volume">39</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">617</span>
                     <span tagx="lpage">631</span>
                     <div tagxxx="pub-id">2-s2.0-0024202981</div>
                     <div tagxxx="pub-id">2462795</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">60</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Thibodeaux</span>
                           <span tagx="given-names">BA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Garbino</span>
                           <span tagx="given-names">NC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Liss</span>
                           <span tagx="given-names">NM</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow
                        fever infection in an AG129/17D-204 peripheral challenge mouse model
                     </span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">94</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">1</span>
                     <span tagx="lpage">8</span>
                     <div tagxxx="pub-id">2-s2.0-84857990014</div>
                     <div tagxxx="pub-id">22366350</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">61</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Daffis</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kontermann</span>
                           <span tagx="given-names">RE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Korimbocus</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Zeller</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Klenk</span>
                           <span tagx="given-names">H-D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ter Meulen</span>
                           <span tagx="given-names">J</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antibody responses against wild-type yellow fever virus and the 17D vaccine strain:
                        characterization with human monoclonal antibody fragments and neutralization escape
                        variants
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">337</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">262</span>
                     <span tagx="lpage">272</span>
                     <div tagxxx="pub-id">2-s2.0-20444414884</div>
                     <div tagxxx="pub-id">15919103</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">62</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Levanov</span>
                           <span tagx="given-names">LN</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Matveev</span>
                           <span tagx="given-names">LE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goncharova</span>
                           <span tagx="given-names">EP</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Chimeric antibodies against tick-borne encephalitis virus</span>
                     <span tagx="source">
                        <i>Vaccine</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">28</span>
                     <div tagxxx="issue">32</div>
                     <span tagx="fpage">5265</span>
                     <span tagx="lpage">5271</span>
                     <div tagxxx="pub-id">2-s2.0-77954951484</div>
                     <div tagxxx="pub-id">20538092</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">63</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hunt</span>
                           <span tagx="given-names">AR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Frederickson</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hinkel</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bowdish</span>
                           <span tagx="given-names">KS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                     </div>
                     <span tagx="article-title">A humanized murine monoclonal antibody protects mice either before or after challenge
                        with virulent Venezuelan equine encephalomyelitis virus
                     </span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">87</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">2467</span>
                     <span tagx="lpage">2476</span>
                     <div tagxxx="pub-id">2-s2.0-33747354579</div>
                     <div tagxxx="pub-id">16894184</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">64</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">da Silva Voorham</span>
                           <span tagx="given-names">JM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rodenhuis-Zybert</span>
                           <span tagx="given-names">IA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nuñez</span>
                           <span tagx="given-names">NVA</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Antibodies against the envelope glycoprotein promote infectivity of immature dengue
                        virus serotype 2
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">3</div>
                     <div tagxxx="pub-id">2-s2.0-84858204844</div>
                     <div tagxxx="pub-id">e29957</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">65</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Pierson</span>
                           <span tagx="given-names">TC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Xu</span>
                           <span tagx="given-names">Q</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nelson</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">The stoichiometry of antibody-mediated neutralization and enhancement of west nile
                        virus infection
                     </span>
                     <span tagx="source">
                        <i>Cell Host and Microbe</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">1</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">135</span>
                     <span tagx="lpage">145</span>
                     <div tagxxx="pub-id">2-s2.0-34147133789</div>
                     <div tagxxx="pub-id">18005691</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">66</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Sautto</span>
                           <span tagx="given-names">G</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Diotti</span>
                           <span tagx="given-names">RA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Solforosi</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                     </div>
                     <span tagx="article-title">Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization
                        interference
                     </span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">96</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">82</span>
                     <span tagx="lpage">89</span>
                     <div tagxxx="pub-id">22898087</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">67</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Matsuura</span>
                           <span tagx="given-names">Y</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments
                        derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV
                        pseudotype
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">76</span>
                     <div tagxxx="issue">22</div>
                     <span tagx="fpage">11775</span>
                     <span tagx="lpage">11779</span>
                     <div tagxxx="pub-id">2-s2.0-0036827644</div>
                     <div tagxxx="pub-id">12388741</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">68</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Phillpotts</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Stephenson</span>
                           <span tagx="given-names">JR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Porterfield</span>
                           <span tagx="given-names">JS</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antibody-dependent enhancement of tick-borne encephalitus virus infectivity</span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">1985</span>
                     <span tagx="volume">66</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">1831</span>
                     <span tagx="lpage">1837</span>
                     <div tagxxx="pub-id">2-s2.0-0021848969</div>
                     <div tagxxx="pub-id">2991448</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">69</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Dowd</span>
                           <span tagx="given-names">KA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pierson</span>
                           <span tagx="given-names">TC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antibody-mediated neutralization of flaviviruses: a reductionist view</span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">411</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">306</span>
                     <span tagx="lpage">315</span>
                     <div tagxxx="pub-id">2-s2.0-79952071242</div>
                     <div tagxxx="pub-id">21255816</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">70</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Falconar</span>
                           <span tagx="given-names">AKI</span>
                        </div>
                     </div>
                     <span tagx="article-title">Monoclonal antibodies that bind to common epitopes on the dengue virus type 2 nonstructural-1
                        and envelope glycoproteins display weak neutralizing activity and differentiated responses
                        to virulent strains: implications for pathogenesis and vaccines
                     </span>
                     <span tagx="source">
                        <i>Clinical and Vaccine Immunology</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">15</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">549</span>
                     <span tagx="lpage">561</span>
                     <div tagxxx="pub-id">2-s2.0-42049095551</div>
                     <div tagxxx="pub-id">18160621</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">71</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Meyer</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Banerjee</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Frey</span>
                           <span tagx="given-names">SE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Belshe</span>
                           <span tagx="given-names">RB</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ray</span>
                           <span tagx="given-names">R</span>
                        </div>
                     </div>
                     <span tagx="article-title">A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances
                        virus infection
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">8</div>
                     <div tagxxx="pub-id">2-s2.0-80051923476</div>
                     <div tagxxx="pub-id">e23699</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">72</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Williamson</span>
                           <span tagx="given-names">RA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sanna</span>
                           <span tagx="given-names">PP</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bloom</span>
                           <span tagx="given-names">FE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Burton</span>
                           <span tagx="given-names">DR</span>
                        </div>
                     </div>
                     <span tagx="article-title">Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell
                        transmission of herpes simplex viruses 1 and 2 in vitro
                     </span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">1994</span>
                     <span tagx="volume">91</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">355</span>
                     <span tagx="lpage">359</span>
                     <div tagxxx="pub-id">2-s2.0-0028082433</div>
                     <div tagxxx="pub-id">8278393</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">73</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Rolph</span>
                           <span tagx="given-names">MS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Zaid</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rulli</span>
                           <span tagx="given-names">NE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mahalingam</span>
                           <span tagx="given-names">S</span>
                        </div>
                     </div>
                     <span tagx="article-title">Downregulation of interferon-
                        <i>β</i> in antibody-dependent enhancement of dengue viral infections of human macrophages
                        is dependent on interleukin-6
                     </span>
                     <span tagx="source">
                        <i>Journal of Infectious Diseases</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">204</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">489</span>
                     <span tagx="lpage">491</span>
                     <div tagxxx="pub-id">2-s2.0-79960121987</div>
                     <div tagxxx="pub-id">21742851</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">74</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Whitehead</span>
                           <span tagx="given-names">SS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Blaney</span>
                           <span tagx="given-names">JE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Durbin</span>
                           <span tagx="given-names">AP</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Murphy</span>
                           <span tagx="given-names">BR</span>
                        </div>
                     </div>
                     <span tagx="article-title">Prospects for a dengue virus vaccine</span>
                     <span tagx="source">
                        <i>Nature Reviews Microbiology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">5</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">518</span>
                     <span tagx="lpage">528</span>
                     <div tagxxx="pub-id">2-s2.0-34250365710</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">75</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Lok</span>
                           <span tagx="given-names">S-M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kostyuchenko</span>
                           <span tagx="given-names">V</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nybakken</span>
                           <span tagx="given-names">GE</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Binding of a neutralizing antibody to dengue virus alters the arrangement of surface
                        glycoproteins
                     </span>
                     <span tagx="source">
                        <i>Nature Structural and Molecular Biology</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">15</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">312</span>
                     <span tagx="lpage">317</span>
                     <div tagxxx="pub-id">2-s2.0-40949161794</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">76</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Goncalvez</span>
                           <span tagx="given-names">AP</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Men</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wernly</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Purcell</span>
                           <span tagx="given-names">RH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lai</span>
                           <span tagx="given-names">C-J</span>
                        </div>
                     </div>
                     <span tagx="article-title">Chimpanzee Fab fragments and a derived humanized immunogiobulin G1 antibody that efficiently
                        cross-neutralize dengue type 1 and type 2 viruses
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">78</span>
                     <div tagxxx="issue">23</div>
                     <span tagx="fpage">12910</span>
                     <span tagx="lpage">12918</span>
                     <div tagxxx="pub-id">2-s2.0-8644261541</div>
                     <div tagxxx="pub-id">15542643</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">77</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Wahala</span>
                           <span tagx="given-names">WMPB</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kraus</span>
                           <span tagx="given-names">AA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Haymore</span>
                           <span tagx="given-names">LB</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Accavitti-Loper</span>
                           <span tagx="given-names">MA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">de Silva</span>
                           <span tagx="given-names">AM</span>
                        </div>
                     </div>
                     <span tagx="article-title">Dengue virus neutralization by human immune sera: role of envelope protein domain
                        III-reactive antibody
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">392</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">103</span>
                     <span tagx="lpage">113</span>
                     <div tagxxx="pub-id">2-s2.0-69249213373</div>
                     <div tagxxx="pub-id">19631955</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">78</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Crill</span>
                           <span tagx="given-names">WD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hughes</span>
                           <span tagx="given-names">HR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Delorey</span>
                           <span tagx="given-names">MJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Chang</span>
                           <span tagx="given-names">G-JJ</span>
                        </div>
                     </div>
                     <span tagx="article-title">Humoral immune responses of dengue fever patients using epitope-specific serotype-2
                        virus-like particle antigens
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">4</span>
                     <div tagxxx="issue">4</div>
                     <div tagxxx="pub-id">2-s2.0-64249106079</div>
                     <div tagxxx="pub-id">e4991</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">79</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Setthapramote</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sasaki</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Puiprom</span>
                           <span tagx="given-names">O</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes
                        from patients at acute phase of the secondary infection
                     </span>
                     <span tagx="source">
                        <i>Biochemical and Biophysical Research Communications</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">423</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">867</span>
                     <span tagx="lpage">872</span>
                     <div tagxxx="pub-id">22713454</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">80</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Beltramello</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Williams</span>
                           <span tagx="given-names">KL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Simmons</span>
                           <span tagx="given-names">CP</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">The human immune response to dengue virus is dominated by highly cross-reactive antibodies
                        endowed with neutralizing and enhancing activity
                     </span>
                     <span tagx="source">
                        <i>Cell Host and Microbe</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">8</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">271</span>
                     <span tagx="lpage">283</span>
                     <div tagxxx="pub-id">2-s2.0-77956605864</div>
                     <div tagxxx="pub-id">20833378</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">81</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Midgley</span>
                           <span tagx="given-names">CM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bajwa-Joseph</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Vasanawathana</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">An in-depth analysis of original antigenic sin in dengue virus infection</span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">85</span>
                     <div tagxxx="issue">22</div>
                     <span tagx="fpage">410</span>
                     <span tagx="lpage">421</span>
                     <div tagxxx="pub-id">2-s2.0-80655142479</div>
                     <div tagxxx="pub-id">20980526</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">82</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Kaufmann</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Vogt</span>
                           <span tagx="given-names">MR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goudsmit</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Neutralization of West Nile virus by cross-linking of its surface proteins with Fab
                        fragments of the human monoclonal antibody CR4354
                     </span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">107</span>
                     <div tagxxx="issue">44</div>
                     <span tagx="fpage">18950</span>
                     <span tagx="lpage">18955</span>
                     <div tagxxx="pub-id">2-s2.0-78650495030</div>
                     <div tagxxx="pub-id">20956322</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">83</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Spurrier</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Sampson</span>
                           <span tagx="given-names">JM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Totrov</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the
                        configuration of the quaternary neutralizing epitope of HIV-1 gp120
                     </span>
                     <span tagx="source">
                        <i>Structure</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">19</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">691</span>
                     <span tagx="lpage">699</span>
                     <div tagxxx="pub-id">2-s2.0-79955855015</div>
                     <div tagxxx="pub-id">21565703</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">84</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Schlesinger</span>
                           <span tagx="given-names">JJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Brandriss</span>
                           <span tagx="given-names">MW</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Monath</span>
                           <span tagx="given-names">TP</span>
                        </div>
                     </div>
                     <span tagx="article-title">Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever
                        virus by neutralization, hemagglutination inhibition, and immune precipitation of
                        the virus envelope protein
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">1983</span>
                     <span tagx="volume">125</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">8</span>
                     <span tagx="lpage">17</span>
                     <div tagxxx="pub-id">2-s2.0-0020672355</div>
                     <div tagxxx="pub-id">6187129</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">85</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Brandriss</span>
                           <span tagx="given-names">MW</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Schlesinger</span>
                           <span tagx="given-names">JJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Walsh</span>
                           <span tagx="given-names">EE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Briselli</span>
                           <span tagx="given-names">M</span>
                        </div>
                     </div>
                     <span tagx="article-title">Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal
                        antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses
                     </span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">1986</span>
                     <span tagx="volume">67</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">229</span>
                     <span tagx="lpage">234</span>
                     <div tagxxx="pub-id">2-s2.0-0022638732</div>
                     <div tagxxx="pub-id">3944585</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">86</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Cho</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Diamond</span>
                           <span tagx="given-names">MS</span>
                        </div>
                     </div>
                     <span tagx="article-title">Immune responses to West Nile virus infection in the central nervous system</span>
                     <span tagx="source">
                        <i>Viruses</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">4</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">3812</span>
                     <span tagx="lpage">3830</span>
                     <div tagxxx="pub-id">23247502</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">87</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Beasley</span>
                           <span tagx="given-names">DW</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Barrett</span>
                           <span tagx="given-names">AD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Tesh</span>
                           <span tagx="given-names">RB</span>
                        </div>
                     </div>
                     <span tagx="article-title">Resurgence of West Nile neurologic disease in the United States in 2012: what happened?
                        What needs to be done?
                     </span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">99</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">1</span>
                     <span tagx="lpage">5</span>
                     <div tagxxx="pub-id">23624155</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">88</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Throsby</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ter Meulen</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Geuijen</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goudsmit</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">De Kruif</span>
                           <span tagx="given-names">J</span>
                        </div>
                     </div>
                     <span tagx="article-title">Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects
                        for vaccine development
                     </span>
                     <span tagx="source">
                        <i>Expert Review of Vaccines</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">183</span>
                     <span tagx="lpage">191</span>
                     <div tagxxx="pub-id">2-s2.0-34247223776</div>
                     <div tagxxx="pub-id">17408368</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">89</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Diamond</span>
                           <span tagx="given-names">MS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Roberts</span>
                           <span tagx="given-names">TG</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Edgil</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lu</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ernst</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Harris</span>
                           <span tagx="given-names">E</span>
                        </div>
                     </div>
                     <span tagx="article-title">Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons</span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2000</span>
                     <span tagx="volume">74</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">4957</span>
                     <span tagx="lpage">4966</span>
                     <div tagxxx="pub-id">2-s2.0-0034101043</div>
                     <div tagxxx="pub-id">10799569</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">90</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Shimoni</span>
                           <span tagx="given-names">Z</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Niven</span>
                           <span tagx="given-names">MJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pitlick</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bulvik</span>
                           <span tagx="given-names">S</span>
                        </div>
                     </div>
                     <span tagx="article-title">Treatment of West Nile virus encephalitis with intravenous immunoglobulin</span>
                     <span tagx="source">
                        <i>Emerging Infectious Diseases</i>
                     </span>
                     <span tagx="year">2001</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">4, article 759</div>
                     <div tagxxx="pub-id">2-s2.0-0034847420</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">91</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hamdan</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Green</span>
                           <span tagx="given-names">P</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mendelson</span>
                           <span tagx="given-names">E</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kramer</span>
                           <span tagx="given-names">MR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pitlik</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Weinberger</span>
                           <span tagx="given-names">M</span>
                        </div>
                     </div>
                     <span tagx="article-title">Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient
                        with West Nile virus encephalitis
                     </span>
                     <span tagx="source">
                        <i>Transplant Infectious Disease</i>
                     </span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">4</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">160</span>
                     <span tagx="lpage">162</span>
                     <div tagxxx="pub-id">2-s2.0-0036759080</div>
                     <div tagxxx="pub-id">12421462</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">92</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Haley</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Retter</span>
                           <span tagx="given-names">AS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Fowler</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gea-Banacloche</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">O’Grady</span>
                           <span tagx="given-names">NP</span>
                        </div>
                     </div>
                     <span tagx="article-title">The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis</span>
                     <span tagx="source">
                        <i>Clinical Infectious Diseases</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">37</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">e88</span>
                     <span tagx="lpage">e90</span>
                     <div tagxxx="pub-id">2-s2.0-0346937710</div>
                     <div tagxxx="pub-id">12955669</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">93</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Chung</span>
                           <span tagx="given-names">KM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nybakken</span>
                           <span tagx="given-names">GE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Thompson</span>
                           <span tagx="given-names">BS</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection
                        through Fc 
                        <i>γ</i> receptor-dependent and -independent mechanisms
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">80</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">1340</span>
                     <span tagx="lpage">1351</span>
                     <div tagxxx="pub-id">2-s2.0-31144442443</div>
                     <div tagxxx="pub-id">16415011</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">94</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Henchal</span>
                           <span tagx="given-names">EA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Henchal</span>
                           <span tagx="given-names">LS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Schlesinger</span>
                           <span tagx="given-names">JJ</span>
                        </div>
                     </div>
                     <span tagx="article-title">Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized
                        mice from lethal challenge with dengue 2 virus
                     </span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">1988</span>
                     <span tagx="volume">69</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">2101</span>
                     <span tagx="lpage">2107</span>
                     <div tagxxx="pub-id">2-s2.0-0023784098</div>
                     <div tagxxx="pub-id">3404125</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">95</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                     </div>
                     <span tagx="article-title">Antigenic structure of flavivirus proteins</span>
                     <span tagx="source">
                        <i>Advances in Virus Research</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">59</span>
                     <span tagx="fpage">141</span>
                     <span tagx="lpage">175</span>
                     <div tagxxx="pub-id">2-s2.0-1542466883</div>
                     <div tagxxx="pub-id">14696329</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">96</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Sánchez</span>
                           <span tagx="given-names">MD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pierson</span>
                           <span tagx="given-names">TC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">McAllister</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Characterization of neutralizing antibodies to West Nile virus</span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">336</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">70</span>
                     <span tagx="lpage">82</span>
                     <div tagxxx="pub-id">2-s2.0-18044396710</div>
                     <div tagxxx="pub-id">15866072</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">97</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Beigel</span>
                           <span tagx="given-names">JH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nordstrom</span>
                           <span tagx="given-names">JL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Pillemer</span>
                           <span tagx="given-names">SR</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal
                        antibody to West Nile virus
                     </span>
                     <span tagx="source">
                        <i>Antimicrobial Agents and Chemotherapy</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">54</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">2431</span>
                     <span tagx="lpage">2436</span>
                     <div tagxxx="pub-id">2-s2.0-77952602676</div>
                     <div tagxxx="pub-id">20350945</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">98</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Smeraski</span>
                           <span tagx="given-names">CA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Siddharthan</span>
                           <span tagx="given-names">V</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Morrey</span>
                           <span tagx="given-names">JD</span>
                        </div>
                     </div>
                     <span tagx="article-title">Treatment of spatial memory impairment in hamsters infected with West Nile virus using
                        a humanized monoclonal antibody MGAWN1
                     </span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">91</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">43</span>
                     <span tagx="lpage">49</span>
                     <div tagxxx="pub-id">2-s2.0-79957568770</div>
                     <div tagxxx="pub-id">21554903</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">99</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Lelli</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Moreno</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Brocchi</span>
                           <span tagx="given-names">E</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">West Nile virus: characterization and diagnostic applications of monoclonal antibodies</span>
                     <span tagx="source">
                        <i>Virology Journal</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">9</span>
                     <div tagxxx="issue">article 81</div>
                     <div tagxxx="pub-id">2-s2.0-84859632012</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">100</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Gritsun</span>
                           <span tagx="given-names">TS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lashkevich</span>
                           <span tagx="given-names">VA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gould</span>
                           <span tagx="given-names">EA</span>
                        </div>
                     </div>
                     <span tagx="article-title">Tick-borne encephalitis</span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">57</span>
                     <div tagxxx="issue">1-2</div>
                     <span tagx="fpage">129</span>
                     <span tagx="lpage">146</span>
                     <div tagxxx="pub-id">2-s2.0-12244283132</div>
                     <div tagxxx="pub-id">12615309</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">101</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Růžek</span>
                           <span tagx="given-names">D</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gritsun</span>
                           <span tagx="given-names">TS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Forrester</span>
                           <span tagx="given-names">NL</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Mutations in the NS2B and NS3 genes affect mouse neuroinvasiveness of a Western European
                        field strain of tick-borne encephalitis virus
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">374</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">249</span>
                     <span tagx="lpage">255</span>
                     <div tagxxx="pub-id">2-s2.0-42649113388</div>
                     <div tagxxx="pub-id">18339416</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">102</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Ecker</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Allison</span>
                           <span tagx="given-names">SL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Meixner</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Heinz</span>
                           <span tagx="given-names">FX</span>
                        </div>
                     </div>
                     <span tagx="article-title">Sequence analysis and genetic classification of tick-borne encephalitis viruses from
                        Europe and Asia
                     </span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">80</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">179</span>
                     <span tagx="lpage">185</span>
                     <div tagxxx="pub-id">2-s2.0-0032918492</div>
                     <div tagxxx="pub-id">9934700</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">103</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Holzmann</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Vorobyova</span>
                           <span tagx="given-names">MS</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ladyzhenskaya</span>
                           <span tagx="given-names">IP</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Molecular epidemiology of tick-borne encephalitis virus: cross-protection between
                        European and Far Eastern subtypes
                     </span>
                     <span tagx="source">
                        <i>Vaccine</i>
                     </span>
                     <span tagx="year">1992</span>
                     <span tagx="volume">10</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">345</span>
                     <span tagx="lpage">349</span>
                     <div tagxxx="pub-id">2-s2.0-0026583453</div>
                     <div tagxxx="pub-id">1574920</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">104</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mandl</span>
                           <span tagx="given-names">CW</span>
                        </div>
                     </div>
                     <span tagx="article-title">Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis</span>
                     <span tagx="source">
                        <i>Virus Research</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">111</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">161</span>
                     <span tagx="lpage">174</span>
                     <div tagxxx="pub-id">2-s2.0-21344441475</div>
                     <div tagxxx="pub-id">15871909</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">105</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Atrasheuskaya</span>
                           <span tagx="given-names">AV</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Fredeking</span>
                           <span tagx="given-names">TM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ignatyev</span>
                           <span tagx="given-names">GM</span>
                        </div>
                     </div>
                     <span tagx="article-title">Changes in immune parameters and their correction in human cases of tick-borne encephalitis</span>
                     <span tagx="source">
                        <i>Clinical and Experimental Immunology</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">131</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">148</span>
                     <span tagx="lpage">154</span>
                     <div tagxxx="pub-id">2-s2.0-12244308552</div>
                     <div tagxxx="pub-id">12519399</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">106</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mansfield</span>
                           <span tagx="given-names">KL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Johnson</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phipps</span>
                           <span tagx="given-names">LP</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Stephenson</span>
                           <span tagx="given-names">JR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Fooks</span>
                           <span tagx="given-names">AR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Solomon</span>
                           <span tagx="given-names">T</span>
                        </div>
                     </div>
                     <span tagx="article-title">Tick-borne encephalitis virus—a review of an emerging zoonosis</span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">90</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">1781</span>
                     <span tagx="lpage">1794</span>
                     <div tagxxx="pub-id">2-s2.0-69449087112</div>
                     <div tagxxx="pub-id">19420159</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">107</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Vaughn</span>
                           <span tagx="given-names">DW</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hoke</span>
                           <span tagx="given-names">CH</span>
                           <div tagxxx="suffix">Jr.</div>
                        </div>
                     </div>
                     <span tagx="article-title">The epidemiology of Japanese encephalitis: prospects for prevention</span>
                     <span tagx="source">
                        <i>Epidemiologic Reviews</i>
                     </span>
                     <span tagx="year">1992</span>
                     <span tagx="volume">14</span>
                     <span tagx="fpage">197</span>
                     <span tagx="lpage">221</span>
                     <div tagxxx="pub-id">2-s2.0-0027049680</div>
                     <div tagxxx="pub-id">1337744</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">108</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Solomon</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ni</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Beasley</span>
                           <span tagx="given-names">DWC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ekkelenkamp</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Cardosa</span>
                           <span tagx="given-names">MJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Barrett</span>
                           <span tagx="given-names">ADT</span>
                        </div>
                     </div>
                     <span tagx="article-title">Origin and evolution of Japanese encephalitis virus in Southeast Asia</span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">77</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">3091</span>
                     <span tagx="lpage">3098</span>
                     <div tagxxx="pub-id">2-s2.0-0037372114</div>
                     <div tagxxx="pub-id">12584335</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">109</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Wilson</span>
                           <span tagx="given-names">MR</span>
                        </div>
                     </div>
                     <span tagx="article-title">Emerging viral infections</span>
                     <span tagx="source">
                        <i>Current Opinion in Neurology</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">26</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">301</span>
                     <span tagx="lpage">306</span>
                     <div tagxxx="pub-id">23591683</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">110</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hanna</span>
                           <span tagx="given-names">JN</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ritchie</span>
                           <span tagx="given-names">SA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phillips</span>
                           <span tagx="given-names">DA</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995</span>
                     <span tagx="source">
                        <i>Medical Journal of Australia</i>
                     </span>
                     <span tagx="year">1996</span>
                     <span tagx="volume">165</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">256</span>
                     <span tagx="lpage">260</span>
                     <div tagxxx="pub-id">2-s2.0-0029797719</div>
                     <div tagxxx="pub-id">8816682</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">111</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hanna</span>
                           <span tagx="given-names">JN</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ritchie</span>
                           <span tagx="given-names">SA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phillips</span>
                           <span tagx="given-names">DA</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Japanese encephalitis in north Queensland, Australia, 1998</span>
                     <span tagx="source">
                        <i>Medical Journal of Australia</i>
                     </span>
                     <span tagx="year">1999</span>
                     <span tagx="volume">170</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">533</span>
                     <span tagx="lpage">536</span>
                     <div tagxxx="pub-id">2-s2.0-0033532620</div>
                     <div tagxxx="pub-id">10397044</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">112</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">George</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gourie-Devi</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rao</span>
                           <span tagx="given-names">JA</span>
                        </div>
                     </div>
                     <span tagx="article-title">Isolation of West Nile virus from the brains of children who had died of encephalitis</span>
                     <span tagx="source">
                        <i>Bulletin of the World Health Organization</i>
                     </span>
                     <span tagx="year">1984</span>
                     <span tagx="volume">62</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">879</span>
                     <span tagx="lpage">882</span>
                     <div tagxxx="pub-id">2-s2.0-0021704586</div>
                     <div tagxxx="pub-id">6099760</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">113</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Gupta</span>
                           <span tagx="given-names">AK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Koshy</span>
                           <span tagx="given-names">AA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Lad</span>
                           <span tagx="given-names">VJ</span>
                        </div>
                     </div>
                     <span tagx="article-title">Enhanced protection of mice against Japanese encephalitis virus infection by combinations
                        of monoclonal antibodies to glycoprotein E
                     </span>
                     <span tagx="source">
                        <i>Acta Virologica</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">55</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">165</span>
                     <span tagx="lpage">168</span>
                     <div tagxxx="pub-id">2-s2.0-80052795725</div>
                     <div tagxxx="pub-id">21692566</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">114</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">TH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Song</span>
                           <span tagx="given-names">B-H</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Yun</span>
                           <span tagx="given-names">S-I</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A cross-protective mAb recognizes a novel epitope within the flavivirus NS1 protein</span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">93</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">20</span>
                     <span tagx="lpage">26</span>
                     <div tagxxx="pub-id">2-s2.0-83755173089</div>
                     <div tagxxx="pub-id">21918007</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">115</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Weaver</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Host range, amplification and arboviral disease emergence</span>
                     <span tagx="source">
                        <i>Archives of Virology. Supplementum</i>
                     </span>
                     <span tagx="year">2005</span>
                     <div tagxxx="issue">19</div>
                     <span tagx="fpage">33</span>
                     <span tagx="lpage">44</span>
                     <div tagxxx="pub-id">2-s2.0-33644837097</div>
                     <div tagxxx="pub-id">16358422</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">116</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Solignat</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gay</span>
                           <span tagx="given-names">B</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Higgs</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Briant</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Devaux</span>
                           <span tagx="given-names">C</span>
                        </div>
                     </div>
                     <span tagx="article-title">Replication cycle of chikungunya: a re-emerging arbovirus</span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">393</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">183</span>
                     <span tagx="lpage">197</span>
                     <div tagxxx="pub-id">2-s2.0-70350001140</div>
                     <div tagxxx="pub-id">19732931</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">117</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Schwartz</span>
                           <span tagx="given-names">O</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Albert</span>
                           <span tagx="given-names">ML</span>
                        </div>
                     </div>
                     <span tagx="article-title">Biology and pathogenesis of chikungunya virus</span>
                     <span tagx="source">
                        <i>Nature Reviews Microbiology</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">8</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">491</span>
                     <span tagx="lpage">500</span>
                     <div tagxxx="pub-id">2-s2.0-77953552629</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">118</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Akahata</span>
                           <span tagx="given-names">W</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Yang</span>
                           <span tagx="given-names">Z-Y</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Andersen</span>
                           <span tagx="given-names">H</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates
                        against infection
                     </span>
                     <span tagx="source">
                        <i>Nature Medicine</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">16</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">334</span>
                     <span tagx="lpage">338</span>
                     <div tagxxx="pub-id">2-s2.0-77949264955</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">119</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Kielian</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Helenius</span>
                           <span tagx="given-names">A</span>
                        </div>
                     </div>
                     <span tagx="article-title">pH-Iinduced alterations in the fusogenic spike protein of Semliki Forest virus</span>
                     <span tagx="source">
                        <i>Journal of Cell Biology</i>
                     </span>
                     <span tagx="year">1985</span>
                     <span tagx="volume">101</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">2284</span>
                     <span tagx="lpage">2291</span>
                     <div tagxxx="pub-id">2-s2.0-0022273625</div>
                     <div tagxxx="pub-id">3905823</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">120</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">White</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Helenius</span>
                           <span tagx="given-names">A</span>
                        </div>
                     </div>
                     <span tagx="article-title">pH-Dependent fusion between the Semliki Forest virus membrane and liposomes</span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">1980</span>
                     <span tagx="volume">77</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">3273</span>
                     <span tagx="lpage">3277</span>
                     <div tagxxx="pub-id">2-s2.0-0001696895</div>
                     <div tagxxx="pub-id">6997876</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">121</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Dubuisson</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rice</span>
                           <span tagx="given-names">CM</span>
                        </div>
                     </div>
                     <span tagx="article-title">Sindbis virus attachment: isolation and characterization of mutants with impaired
                        binding to vertebrate cells
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1993</span>
                     <span tagx="volume">67</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">3363</span>
                     <span tagx="lpage">3374</span>
                     <div tagxxx="pub-id">2-s2.0-0027192904</div>
                     <div tagxxx="pub-id">7684466</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">122</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Lee</span>
                           <span tagx="given-names">CY</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kam</span>
                           <span tagx="given-names">Y-W</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Fric</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Chikungunya virus neutralization antigens and direct cell-to-cell transmission are
                        revealed by human antibody-escape mutants
                     </span>
                     <span tagx="source">
                        <i>PLoS Pathogens</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">12</div>
                     <div tagxxx="pub-id">2-s2.0-84855319039</div>
                     <div tagxxx="pub-id">e1002390</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">123</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Voss</span>
                           <span tagx="given-names">JE</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Vaney</span>
                           <span tagx="given-names">M-C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Duquerroy</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">468</span>
                     <div tagxxx="issue">7324</div>
                     <span tagx="fpage">709</span>
                     <span tagx="lpage">712</span>
                     <div tagxxx="pub-id">2-s2.0-78649817910</div>
                     <div tagxxx="pub-id">21124458</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">124</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Jose</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Xiang</span>
                           <span tagx="given-names">Y</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Kuhn</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Rossmann</span>
                           <span tagx="given-names">MG</span>
                        </div>
                     </div>
                     <span tagx="article-title">Structural changes of envelope proteins during alphavirus fusion</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">468</span>
                     <div tagxxx="issue">7324</div>
                     <span tagx="fpage">705</span>
                     <span tagx="lpage">708</span>
                     <div tagxxx="pub-id">2-s2.0-78649891889</div>
                     <div tagxxx="pub-id">21124457</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">125</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Fric</span>
                           <span tagx="given-names">J</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bertin-Maghit</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Wang</span>
                           <span tagx="given-names">CI</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Nardin</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Warter</span>
                           <span tagx="given-names">L</span>
                        </div>
                     </div>
                     <span tagx="article-title">Use of human monoclonal antibodies to treat Chikungunya virus infection</span>
                     <span tagx="source">
                        <i>Journal of Infectious Diseases</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">207</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">319</span>
                     <span tagx="lpage">322</span>
                     <div tagxxx="pub-id">23125446</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">126</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Aguilar</span>
                           <span tagx="given-names">PV</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Estrada-Franco</span>
                           <span tagx="given-names">JG</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Navarro-Lopez</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ferro</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Haddow</span>
                           <span tagx="given-names">AD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Weaver</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella</span>
                     <span tagx="source">
                        <i>Future Virology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">721</span>
                     <span tagx="lpage">740</span>
                     <div tagxxx="pub-id">2-s2.0-79958253204</div>
                     <div tagxxx="pub-id">21765860</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">127</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Weaver</span>
                           <span tagx="given-names">SC</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Winegar</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Manger</span>
                           <span tagx="given-names">ID</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Forrester</span>
                           <span tagx="given-names">NL</span>
                        </div>
                     </div>
                     <span tagx="article-title">Alphaviruses: population genetics and determinants of emergence</span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">94</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">242</span>
                     <span tagx="lpage">257</span>
                     <div tagxxx="pub-id">22522323</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">128</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Paessler</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Weaver</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Vaccines for Venezuelan equine encephalitis</span>
                     <span tagx="source">
                        <i>Vaccine</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">27</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">D80</span>
                     <span tagx="lpage">D85</span>
                     <div tagxxx="pub-id">2-s2.0-77958168896</div>
                     <div tagxxx="pub-id">19837294</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">129</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Phillpotts</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                     </div>
                     <span tagx="article-title">Venezuelan equine encephalitis virus complex-specific monoclonal antibody provides
                        broad protection, in murine models, against airborne challenge with viruses from serogroups
                        I, II and III
                     </span>
                     <span tagx="source">
                        <i>Virus Research</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">120</span>
                     <div tagxxx="issue">1-2</div>
                     <span tagx="fpage">107</span>
                     <span tagx="lpage">112</span>
                     <div tagxxx="pub-id">2-s2.0-33747015784</div>
                     <div tagxxx="pub-id">16621103</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">130</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Phillpotts</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Jones</span>
                           <span tagx="given-names">LD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Howard</span>
                           <span tagx="given-names">SC</span>
                        </div>
                     </div>
                     <span tagx="article-title">Monoclonal antibody protects mice against infection and disease when given either
                        before or up to 24 h after airborne challenge with virulent Venezuelan equine encephalitis
                        virus
                     </span>
                     <span tagx="source">
                        <i>Vaccine</i>
                     </span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">20</span>
                     <div tagxxx="issue">11-12</div>
                     <span tagx="fpage">1497</span>
                     <span tagx="lpage">1504</span>
                     <div tagxxx="pub-id">2-s2.0-0037154855</div>
                     <div tagxxx="pub-id">11858855</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">131</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mathews</span>
                           <span tagx="given-names">JH</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Trent</span>
                           <span tagx="given-names">DW</span>
                        </div>
                     </div>
                     <span tagx="article-title">Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan
                        equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1985</span>
                     <span tagx="volume">55</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">594</span>
                     <span tagx="lpage">600</span>
                     <div tagxxx="pub-id">2-s2.0-0022219684</div>
                     <div tagxxx="pub-id">2410632</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">132</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">O’Brien</span>
                           <span tagx="given-names">LM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Underwood-Fowler</span>
                           <span tagx="given-names">CD</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goodchild</span>
                           <span tagx="given-names">SA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phelps</span>
                           <span tagx="given-names">AL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phillpotts</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                     </div>
                     <span tagx="article-title">Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan
                        equine encephalitis virus strains
                     </span>
                     <span tagx="source">
                        <i>Virology Journal</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">6, article 206</span>
                     <div tagxxx="pub-id">2-s2.0-73349098374</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">133</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">O’Brien</span>
                           <span tagx="given-names">LM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Goodchild</span>
                           <span tagx="given-names">SA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phillpotts</span>
                           <span tagx="given-names">RJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Perkins</span>
                           <span tagx="given-names">SD</span>
                        </div>
                     </div>
                     <span tagx="article-title">A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis
                        virus, Everglades virus and Mucambo virus when administered up to 48h after airborne
                        challenge
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">426</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">100</span>
                     <span tagx="lpage">105</span>
                     <div tagxxx="pub-id">2-s2.0-84857791634</div>
                     <div tagxxx="pub-id">22341308</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">134</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Mancini</span>
                           <span tagx="given-names">N</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Solforosi</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Castelli</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Clementi</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Burioni</span>
                           <span tagx="given-names">R</span>
                        </div>
                     </div>
                     <span tagx="article-title">Phage display-based strategies for cloning and optimization of monoclonal antibodies
                        directed against human pathogens
                     </span>
                     <span tagx="source">
                        <i>International Journal of Molecular Sciences</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">13</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">8273</span>
                     <span tagx="lpage">8292</span>
                     <div tagxxx="pub-id">22942702</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">135</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hunt</span>
                           <span tagx="given-names">AR</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Bowen</span>
                           <span tagx="given-names">RA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Frederickson</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Maruyama</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Roehrig</span>
                           <span tagx="given-names">JT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Blair</span>
                           <span tagx="given-names">CD</span>
                        </div>
                     </div>
                     <span tagx="article-title">Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge
                        with virulent Venezuelan equine encephalitis virus prevents disease but not infection
                     </span>
                     <span tagx="source">
                        <i>Virology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">414</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">146</span>
                     <span tagx="lpage">152</span>
                     <div tagxxx="pub-id">2-s2.0-79955927334</div>
                     <div tagxxx="pub-id">21489591</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">136</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hu</span>
                           <span tagx="given-names">W-G</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Phelps</span>
                           <span tagx="given-names">AL</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Jager</span>
                           <span tagx="given-names">S</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">A recombinant humanized monoclonal antibody completely protects mice against lethal
                        challenge with Venezuelan equine encephalitis virus
                     </span>
                     <span tagx="source">
                        <i>Vaccine</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">28</span>
                     <div tagxxx="issue">34</div>
                     <span tagx="fpage">5558</span>
                     <span tagx="lpage">5564</span>
                     <div tagxxx="pub-id">2-s2.0-77955056640</div>
                     <div tagxxx="pub-id">20600509</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">137</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Rulker</span>
                           <span tagx="given-names">T</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Voss</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Thullier</span>
                           <span tagx="given-names">P</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates
                        VEEV in vitro and in vivo
                     </span>
                     <span tagx="source">
                        <i>PLoS ONE</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">7</span>
                     <div tagxxx="issue">5</div>
                     <div tagxxx="pub-id">e37242</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">138</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Walter</span>
                           <span tagx="given-names">CT</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Barr</span>
                           <span tagx="given-names">JN</span>
                        </div>
                     </div>
                     <span tagx="article-title">Recent advances in the molecular and cellular biology of bunyaviruses</span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">92</span>
                     <div tagxxx="issue">11</div>
                     <span tagx="fpage">2467</span>
                     <span tagx="lpage">2484</span>
                     <div tagxxx="pub-id">2-s2.0-80053934670</div>
                     <div tagxxx="pub-id">21865443</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">139</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Whitehouse</span>
                           <span tagx="given-names">CA</span>
                        </div>
                     </div>
                     <span tagx="article-title">Crimean-Congo hemorrhagic fever</span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">64</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">145</span>
                     <span tagx="lpage">160</span>
                     <div tagxxx="pub-id">2-s2.0-8644231560</div>
                     <div tagxxx="pub-id">15550268</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">140</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Mertens</span>
                           <span tagx="given-names">M</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Schmidt</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Ozkul</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Groschup</span>
                           <span tagx="given-names">MH</span>
                        </div>
                     </div>
                     <span tagx="article-title">The impact of Crimean-Congo hemorrhagic fever virus on public health</span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">98</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">248</span>
                     <span tagx="lpage">260</span>
                     <div tagxxx="pub-id">23458713</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">141</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Ahmed</span>
                           <span tagx="given-names">AA</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">McFalls</span>
                           <span tagx="given-names">JM</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Hoffmann</span>
                           <span tagx="given-names">C</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Presence of broadly reactive and group-specific neutralizing epitopes on newly described
                        isolates of Crimean-Congo hemorrhagic fever virus
                     </span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">86</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">3327</span>
                     <span tagx="lpage">3336</span>
                     <div tagxxx="pub-id">2-s2.0-28044473870</div>
                     <div tagxxx="pub-id">16298978</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">142</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Hewson</span>
                           <span tagx="given-names">R</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gmyl</span>
                           <span tagx="given-names">A</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Gmyl</span>
                           <span tagx="given-names">L</span>
                        </div>
                        <div tagxxx="etal"></div>
                     </div>
                     <span tagx="article-title">Evidence of segment reassortment in Crimean-Congo haemorrhagic fever virus</span>
                     <span tagx="source">
                        <i>Journal of General Virology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">85</span>
                     <div tagxxx="issue">10</div>
                     <span tagx="fpage">3059</span>
                     <span tagx="lpage">3070</span>
                     <div tagxxx="pub-id">2-s2.0-5444246152</div>
                     <div tagxxx="pub-id">15448369</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">143</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Blackburn</span>
                           <span tagx="given-names">NK</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Besselaar</span>
                           <span tagx="given-names">TG</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Shepherd</span>
                           <span tagx="given-names">AJ</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Swanepoel</span>
                           <span tagx="given-names">R</span>
                        </div>
                     </div>
                     <span tagx="article-title">Preparation and use of monoclonal antibodies for identifying Crimean-Congo hemorrhagic
                        fever virus
                     </span>
                     <span tagx="source">
                        <i>American Journal of Tropical Medicine and Hygiene</i>
                     </span>
                     <span tagx="year">1987</span>
                     <span tagx="volume">37</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">392</span>
                     <span tagx="lpage">397</span>
                     <div tagxxx="pub-id">2-s2.0-0023520173</div>
                     <div tagxxx="pub-id">3116871</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">144</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Ikegami</span>
                           <span tagx="given-names">T</span>
                        </div>
                     </div>
                     <span tagx="article-title">Molecular biology and genetic diversity of Rift Valley fever virus</span>
                     <span tagx="source">
                        <i>Antiviral Research</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">95</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">293</span>
                     <span tagx="lpage">310</span>
                     <div tagxxx="pub-id">22710362</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">145</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Keegan</span>
                           <span tagx="given-names">K</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Collett</span>
                           <span tagx="given-names">MS</span>
                        </div>
                     </div>
                     <span tagx="article-title">Use of bacterial expression cloning to define the amino acid sequences of antigenic
                        determinants on the G2 glycoprotein of Rift Valley fever virus
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1986</span>
                     <span tagx="volume">58</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">263</span>
                     <span tagx="lpage">270</span>
                     <div tagxxx="pub-id">2-s2.0-0022472667</div>
                     <div tagxxx="pub-id">2422392</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">146</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Besselaar</span>
                           <span tagx="given-names">TG</span>
                        </div>
                        <div tagxxx="name">
                           <span tagx="surname">Blackburn</span>
                           <span tagx="given-names">NK</span>
                        </div>
                     </div>
                     <span tagx="article-title">Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins
                        using monoclonal antibodies
                     </span>
                     <span tagx="source">
                        <i>Archives of Virology</i>
                     </span>
                     <span tagx="year">1991</span>
                     <span tagx="volume">121</span>
                     <div tagxxx="issue">1–4</div>
                     <span tagx="fpage">111</span>
                     <span tagx="lpage">124</span>
                     <div tagxxx="pub-id">2-s2.0-0026366106</div>
                     <div tagxxx="pub-id">1722089</div>
                  </div>
               </li>
               <li tag="ref">
                  <div tagxxx="label">147</div>
                  <div tagxxx="element-citation">
                     <div tagxxx="person-group">
                        <div tagxxx="name">
                           <span tagx="surname">Presta</span>
                           <span tagx="given-names">LG</span>
                        </div>
                     </div>
                     <span tagx="article-title">Engineering of therapeutic antibodies to minimize immunogenicity and optimize function</span>
                     <span tagx="source">
                        <i>Advanced Drug Delivery Reviews</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">58</span>
                     <div tagxxx="issue">5-6</div>
                     <span tagx="fpage">640</span>
                     <span tagx="lpage">656</span>
                     <div tagxxx="pub-id">2-s2.0-33747616656</div>
                     <div tagxxx="pub-id">16904789</div>
                  </div>
               </li>
            </ul>
         </div>
      </div>
      <div tagxxx="floats-group">
         <div tagxxx="fig">
            <div tagxxx="label">Figure 1</div>
            <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
               <p>Mechanisms of antibody-dependent enhancement (ADE) of infection. (a) After binding
                  to the viral epitope, the Ab is recognized by a cellular Fc-
                  <i>γ</i> receptor, bringing the viral particle in proximity of the target cell; (b) the binding
                  of the Ab induces conformational changes within the structure of the viral target
                  protein. These changes improve the affinity for the cellular receptor; (c) molecular
                  mimicry by a viral motif of cellular membrane components leads an autoreactive Ab
                  to bind both the viral and the cellular target, bringing the virus in proximity of
                  the target cell.
               </p>
            </caption>
            <div tagxxx="graphic"></div>
         </div>
         <div tagxxx="table-wrap">
            <div tagxxx="label">Table 1</div>
            <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
               <p>Schematic summary of the best characterized mAbs against arboviral pathogens.</p>
            </caption>
            <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hsidesgroups
               <thead>
                  <tr>
                     <div tagxxx="th">mAb</div>
                     <div tagxxx="th">Origin</div>
                     <div tagxxx="th">Reactivity</div>
                     <div tagxxx="th">Target protein</div>
                     <div tagxxx="th">Epitope</div>
                     <div tagxxx="th">Cloning strategy</div>
                     <div tagxxx="th">Format/isotype</div>
                     <div tagxxx="th">Neutralizing activity</div>
                     <div tagxxx="th">Reference</div>
                  </tr>
               </thead>
               <div tagxxx="tbody">
                  <tr>
                     <td>left114.8A</td>
                     <td>left31Human</td>
                     <td>left31DENV1–4</td>
                     <td>center31E</td>
                     <td>left31DII</td>
                     <td>left31EBV transformation</td>
                     <td>left31IgG</td>
                     <td>left11IC50 (
                        <i>μ</i>g/mL): 
                        <div tagxxx="break"></div>DENV1: 1.5
                        <div tagxxx="break"></div>DENV2: &gt;40
                        <div tagxxx="break"></div>DENV3: 2.4
                        <div tagxxx="break"></div>DENV4: &gt;40
                     </td>
                     <td>left31 [
                        <span ref-type="bibr" rid="B65">37</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left11D11C</td>
                     <td>left11IC50 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV1: 1.5
                        <div tagxxx="break"></div>DENV2: 1.0
                        <div tagxxx="break"></div>DENV3: 10.2
                        <div tagxxx="break"></div>DENV4: 1.6
                     </td>
                  </tr>
                  <tr>
                     <td>left111.6D</td>
                     <td>left11IC50 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV1: 1.5
                        <div tagxxx="break"></div>DENV2: 0.2
                        <div tagxxx="break"></div>DENV3: 0.5
                        <div tagxxx="break"></div>DENV4: 2.7
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left112H12</td>
                     <td>left11Murine</td>
                     <td>left11DENV1–4</td>
                     <td>center11E</td>
                     <td>left11DIII (AB loop: aa 314–317)</td>
                     <td>left11Hybridoma from BALB/c mouse immunized with DENV2 E/DIII</td>
                     <td>left11IgG2b</td>
                     <td>left11IC50 nM: 
                        <div tagxxx="break"></div>DENV1: 0.56–54
                        <div tagxxx="break"></div>DENV3: 29
                        <div tagxxx="break"></div>DENV4: 145
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B51">38</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11C9</td>
                     <td>left11Murine/chimeric</td>
                     <td>left11DENV2</td>
                     <td>center11E</td>
                     <td>left11DIII</td>
                     <td>left11Phage display of a chimeric murine hybridoma library</td>
                     <td>left11VH1/V
                        <i>κ</i>1
                     </td>
                     <td>left11PRNT50 
                        <div tagxxx="break"></div>850 
                        <i>μ</i>g/mL
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B48">39</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left114E11</td>
                     <td>left11Murine</td>
                     <td>left11DENV1–4</td>
                     <td>center11E</td>
                     <td>left11DIII (strand A: 308, 312 and strand G: 387, 389, 391)</td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG2a/
                        <i>κ</i>
                     </td>
                     <td>left11IC50 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV10.16
                        <div tagxxx="break"></div>DENV2: 0.13
                        <div tagxxx="break"></div>DENV-3: 8
                        <div tagxxx="break"></div>DENV-4: 15
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B50">40</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left114G2</td>
                     <td>left11Murine</td>
                     <td>left11DENV1–4</td>
                     <td>center11E</td>
                     <td>left11DII (fusion loop)</td>
                     <td>left11Hybridoma from DENV2 E immunized mice</td>
                     <td>left11IgG</td>
                     <td>left11PRNT50 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV2: 15
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B48">39</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left119F12</td>
                     <td>left11Murine</td>
                     <td>left11DENV1–4, WNV</td>
                     <td>center11E</td>
                     <td>left11DIII (aa 305, 307, 310, 330; A strand and BC loop)</td>
                     <td>left11Hybridoma from BALB/c mouse immunized with DENV-2 E/DIII</td>
                     <td>left11IgG1k</td>
                     <td>left11DENV1–4PRNT50: 
                        <div tagxxx="break"></div>2 · 10
                        <sup>−8</sup>–2 · 10
                        <sup>−7</sup> M
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B49">41</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left112A10G6</td>
                     <td>left11Murine</td>
                     <td>left11DENV1–4, YFV, WNV, JEV, TBEV</td>
                     <td>center11E</td>
                     <td>left11DII (Fusion loop: aa 98–101)</td>
                     <td>left11Hybridoma from BALB/c mouse immunized with inactivated DENV2</td>
                     <td>left11IgG1</td>
                     <td>left11PRNT50 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV1: 2
                        <div tagxxx="break"></div>DENV2: 1.5
                        <div tagxxx="break"></div>DENV3: 2.1
                        <div tagxxx="break"></div>DENV4: 1.8
                        <div tagxxx="break"></div>YNF: 3.6
                        <div tagxxx="break"></div>WNV: 46
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B36">36</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11mAb11</td>
                     <td>left11Human</td>
                     <td>left11DENV1–4, WNV, SLEV, YFV, JEV MVEV</td>
                     <td>center11E</td>
                     <td>left11DII (fusion loop)</td>
                     <td>left11Phage display of human scFv</td>
                     <td>left11Fusion protein scFv-Fc</td>
                     <td>left11PRNT80 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>WNV: 1.25
                        <div tagxxx="break"></div>DENV2: 6.25
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B82">42</span>, 
                        <span ref-type="bibr" rid="B83">43</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11E16
                        <div tagxxx="break"></div>(MGAWN1)
                     </td>
                     <td>left11Murine</td>
                     <td>left11WNV</td>
                     <td>center11E</td>
                     <td>left11DIII (LR; aa 302–309)</td>
                     <td>left11Hybridoma from immunized mice with WNV E</td>
                     <td>left11IgG2b/humanized</td>
                     <td>left11PRNT50: 4–18 ng
                        <div tagxxx="break"></div>PRNT90: 53–297 ng
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B84">44</span>, 
                        <span ref-type="bibr" rid="B85">45</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left111A1D-2</td>
                     <td>left11Murine</td>
                     <td>left11DENV1–3</td>
                     <td>center11E</td>
                     <td>left11DIII (A strand: aa 307, 310 and 312)</td>
                     <td>left11Hybridoma from immunized mice with different pH-treated virus</td>
                     <td>left11IgG2a</td>
                     <td>left11DENV2 PRNT50: 
                        <div tagxxx="break"></div>2.1 nM
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B54">46</span>, 
                        <span ref-type="bibr" rid="B86">47</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left111F4</td>
                     <td>left31Human</td>
                     <td>left11DENV1</td>
                     <td>center31E (virion) </td>
                     <td>left11DI-DII</td>
                     <td>left31Electrofusion of infected memory B cells from DENV-immune subjects with EBV</td>
                     <td>left31IgG</td>
                     <td>left11DENV1 IC50
                        <div tagxxx="break"></div>0.11 
                        <i>μ</i>g/mL
                     </td>
                     <td>left31[
                        <span ref-type="bibr" rid="B62">48</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left112D22</td>
                     <td>left11DENV2</td>
                     <td>left11DIII</td>
                     <td>left11DENV2 IC50
                        <div tagxxx="break"></div>0.08 
                        <i>μ</i>g/mL
                     </td>
                  </tr>
                  <tr>
                     <td>left115J7</td>
                     <td>left11DENV3</td>
                     <td>left11DI-DII</td>
                     <td>left11DENV3 IC50
                        <div tagxxx="break"></div>0.10 
                        <i>μ</i>g/mL
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11E105</td>
                     <td>left31Murine</td>
                     <td>left31DENV1</td>
                     <td>center31E</td>
                     <td>left11DIII (BC loop: G328, T329 and D330; DE loop: K361E and E362K; FG loop: K385)
                        <div tagxxx="break"></div>
                     </td>
                     <td>left31Hybridomas derived from C57BL/6 IFN-
                        <i>αβ</i>R
                        <sup>−/−</sup> mice infected with DENV1
                     </td>
                     <td>left31IgG</td>
                     <td>left11PRNT50 DENV-1: 0.5–59.2 ng/mL</td>
                     <td>left21[
                        <span ref-type="bibr" rid="B32">32</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left11E106</td>
                     <td>left11DIII (BC loop: G328, T329 and D330; DE loop: K361E and E362K; FG loop: K385; A strand:
                        S305, K307, E309, K310, and E311)
                        <div tagxxx="break"></div>
                     </td>
                     <td>left11PRNT50 DENV-1: 0.6–59.2 ng/mL</td>
                  </tr>
                  <tr>
                     <td>left11E111</td>
                     <td>left11DIII (CC′ loop)</td>
                     <td>left11PRNT50:  
                        <div tagxxx="break"></div>3.8–25 
                        <i>μ</i>g/mL
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B52">49</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11CR4374</td>
                     <td>left21Human</td>
                     <td>left21WNV</td>
                     <td>center21E</td>
                     <td>left21DIII</td>
                     <td>left21Phage display of scFv IgG library</td>
                     <td>left11VH2-05/VL1e</td>
                     <td>left11PRNT50: 
                        <div tagxxx="break"></div>0.18 
                        <i>μ</i>g/mL
                        <div tagxxx="break"></div>PRNT90:  
                        <div tagxxx="break"></div>0.95 
                        <i>μ</i>g/mL
                     </td>
                     <td>left21[
                        <span ref-type="bibr" rid="B80">50</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left11CR4353</td>
                     <td>left11VH3-30/Vk3-A27</td>
                     <td>left11PRNT50: 
                        <div tagxxx="break"></div>0.026 
                        <i>μ</i>g/mL
                        <div tagxxx="break"></div>PRNT90 
                        <div tagxxx="break"></div>36.4 
                        <i>μ</i>g/mL
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left111A5</td>
                     <td>left11Chimpanzee</td>
                     <td>left11DENV1–4, WNV, JEV, LGTV</td>
                     <td>center11E</td>
                     <td>left11DII (aa G106)</td>
                     <td>left11Phage display of Fab library from DENV1–4 infected chimpanzees</td>
                     <td>left11Humanized IgG1</td>
                     <td>left11PRNT50 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV1: 0.48
                        <div tagxxx="break"></div>DENV2: 0.95
                        <div tagxxx="break"></div>DENV3: 3.2
                        <div tagxxx="break"></div>DENV4: 4.3
                        <div tagxxx="break"></div>WNV/DENV4: 3.8
                        <div tagxxx="break"></div>JEV: 21
                        <div tagxxx="break"></div>LGTV: 28
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B56">51</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11mAb11</td>
                     <td>left11Human</td>
                     <td>left11DENV1–4, WNV</td>
                     <td>center11E</td>
                     <td>left11DII (fusion loop, W101, G104, G106)</td>
                     <td>left11scFv library</td>
                     <td>left11scFv-Fc</td>
                     <td>left11PRNT80 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>DENV2: 6.25
                        <div tagxxx="break"></div>WNV: 1.25
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B82">42</span>, 
                        <span ref-type="bibr" rid="B83">43</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left113B4C-4</td>
                     <td>left81Murine</td>
                     <td>left11SLEV</td>
                     <td>center81E</td>
                     <td>left111a</td>
                     <td>left81Hybridoma</td>
                     <td>left81IgG</td>
                     <td>left11
                        SLEV PRNT: &lt;1.7
                     </td>
                     <td>left81[
                        <span ref-type="bibr" rid="B109">52</span>, 
                        <span ref-type="bibr" rid="B110">53</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left111B2C-5</td>
                     <td>left11SLEV</td>
                     <td>left111b</td>
                     <td>left11SLEV PRNT: &lt;1.7</td>
                  </tr>
                  <tr>
                     <td>left116B5A-2</td>
                     <td>left11SLEV</td>
                     <td>left111c</td>
                     <td>left11SLEV PRNT: 4.8</td>
                  </tr>
                  <tr>
                     <td>left114A4C-4</td>
                     <td>left11SLEV</td>
                     <td>left111d</td>
                     <td>left11SLEV PRNT: 2.9</td>
                  </tr>
                  <tr>
                     <td>left111B5D-1</td>
                     <td>left11SLEV, JEV</td>
                     <td>left112</td>
                     <td>left11SLEV PRNT: &lt;1.7</td>
                  </tr>
                  <tr>
                     <td>left112B5B-3</td>
                     <td>left11SLEV, JEV, MVEV, WNV, YFV</td>
                     <td>left113</td>
                     <td>left11SLEV PRNT: 2.3</td>
                  </tr>
                  <tr>
                     <td>left112B6B-2</td>
                     <td>left11All 
                        <i>Flavivirus </i>
                     </td>
                     <td>left114a</td>
                     <td>left11SLEV PRNT: &lt;1.7</td>
                  </tr>
                  <tr>
                     <td>left116B6C-1</td>
                     <td>left11All 
                        <i>Flavivirus </i>
                     </td>
                     <td>left114b (in DII)</td>
                     <td>left11SLEV PRNT: 2.3</td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11A3</td>
                     <td>left31Chimpanzee</td>
                     <td>left31JEV</td>
                     <td>center31E2</td>
                     <td>left11DI aa. K179</td>
                     <td>left11Phage display</td>
                     <td>left31Humanized</td>
                     <td>left11PRNT50
                        <div tagxxx="break"></div>0.04–0.2 nM
                     </td>
                     <td>left31[
                        <span ref-type="bibr" rid="B107">54</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left11B2</td>
                     <td>left11DII aa. I126</td>
                     <td>left11Phage display</td>
                     <td>left11PRNT50
                        <div tagxxx="break"></div>0.02–2 nM
                     </td>
                  </tr>
                  <tr>
                     <td>left11E3</td>
                     <td>left11DIII aa. G132</td>
                     <td>left11Phage display</td>
                     <td>left11PRNT50
                        <div tagxxx="break"></div>0.14–0.93 nM
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11FabTJE12B02</td>
                     <td>left11Human</td>
                     <td>left11JEV</td>
                     <td>center11E</td>
                     <td>left11N/A</td>
                     <td>left11Phage display</td>
                     <td>left11Fab</td>
                     <td>left11FRNT50 
                        <div tagxxx="break"></div>50.2 
                        <i>µ</i>g/mL
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B106">55</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left115F10</td>
                     <td>left11Human</td>
                     <td>left11CHIKV</td>
                     <td>center11E2</td>
                     <td>left11Domain B</td>
                     <td>left11EBV transformation</td>
                     <td>left11IgG1
                        <b>
                           <i>λ</i>
                        </b>2
                     </td>
                     <td>left11IC50 &lt; 100 ng/mL</td>
                     <td>left21[
                        <span ref-type="bibr" rid="B120">56</span>] 
                     </td>
                  </tr>
                  <tr>
                     <td>left118B10</td>
                     <td>left11Human</td>
                     <td>left11CHIKV</td>
                     <td>center11E1-E2</td>
                     <td>left11E2 Domain A</td>
                     <td>left11EBV transformation</td>
                     <td>left11IgG1k</td>
                     <td>left11IC50 &lt; 100 ng/mL</td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left11CHK-152</td>
                     <td>left11Murine</td>
                     <td>left11CHIKV</td>
                     <td>center11E2</td>
                     <td>left11aa 59</td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG2c</td>
                     <td>left11IC50 1–3 ng/mL</td>
                     <td>left11[
                        <span ref-type="bibr" rid="B122">57</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left1111E7</td>
                     <td>left11Murine</td>
                     <td>left11CCHFV</td>
                     <td>center11Gn</td>
                     <td>left11C-ter</td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG</td>
                     <td>left11PRNT80 diluted 1/2560</td>
                     <td>left11[
                        <span ref-type="bibr" rid="B142">58</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left114-39-CC</td>
                     <td>left11Murine</td>
                     <td>left11RVFV</td>
                     <td>center11G2</td>
                     <td>left11Domain IV</td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG</td>
                     <td>left11PRNT80 diluted 1/20480–1/81920</td>
                     <td>left11[
                        <span ref-type="bibr" rid="B145">59</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left112C9</td>
                     <td>left11Murine</td>
                     <td>left11YFV</td>
                     <td>center11E</td>
                     <td>left11 </td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG2a</td>
                     <td>left11PRNT90: 
                        <div tagxxx="break"></div>1/10
                        <sup>4</sup> 17D
                        <div tagxxx="break"></div>1/10
                        <sup>5.2</sup> Asibi
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B68">60</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left115A
                        <div tagxxx="break"></div>7A
                        <div tagxxx="break"></div>R3(27)
                     </td>
                     <td>left11Human</td>
                     <td>left11YFV</td>
                     <td>center11E</td>
                     <td>left11DI-DII</td>
                     <td>left11Phage display</td>
                     <td>left11ScFv</td>
                     <td>left11PRNT90:
                        <div tagxxx="break"></div>0.1–0.3 
                        <i>μ</i>g/mL
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B69">61</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left1113D6</td>
                     <td>left11Murine</td>
                     <td>left11TBEV</td>
                     <td>center11E</td>
                     <td>left11DIII</td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG/chimeric</td>
                     <td>left11PRNT50: 1.9 
                        <i>μ</i>g/mL
                        <div tagxxx="break"></div>FRNT50: 4.5 
                        <i>μ</i>g/mL
                        <div tagxxx="break"></div>IC50
                        <div tagxxx="break"></div>1.9–16.7 
                        <i>μ</i>g/mL
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B97">62</span>]
                     </td>
                  </tr>
                  <tr>
                     <td>left91
                        <div tagxxx="hr"></div>
                     </td>
                  </tr>
                  <tr>
                     <td>left113B4C-4
                        <div tagxxx="break"></div>(Hy4-26C)
                     </td>
                     <td>left11Murine</td>
                     <td>left11VEEV</td>
                     <td>center11E2</td>
                     <td>left11aa 182–209</td>
                     <td>left11Hybridoma</td>
                     <td>left11IgG/humanized</td>
                     <td>left11PRNT70 (
                        <i>μ</i>g/mL):  
                        <div tagxxx="break"></div>39.4–125
                     </td>
                     <td>left11[
                        <span ref-type="bibr" rid="B131">63</span>]
                     </td>
                  </tr>
               </div>
            </table>
         </div>
      </div>
   </div>
</html>